Single fold system for tissue approximation and fixation

Information

  • Patent Grant
  • 8590761
  • Patent Number
    8,590,761
  • Date Filed
    Friday, March 9, 2007
    17 years ago
  • Date Issued
    Tuesday, November 26, 2013
    10 years ago
Abstract
A single fold system for tissue approximation and fixation is described herein. The devices are advanced in a minimally invasive manner within a patient's body to create at least one fold within a hollow body organ. The system comprises a tissue acquisition and folding device and a tissue stapling or fixation device, each of which is used together as a system. The acquisition device is used to approximate a single fold of tissue from within the hollow body organ and the stapling device is advanced through a main lumen defined through the acquisition device and is used to affix the tissue. The stapling device is keyed to maintain its rotational orientation relative to the acquisition device and to provide the user positional information of the stapling device. The acquisition device is also configured to provide lateral stability to the stapling device prior to the stapling device being clamped onto tissue.
Description
FIELD OF THE INVENTION

The present invention relates generally to medical apparatus and methods. More particularly, it relates to devices and methods for approximating portions of a hollow body organ, particularly a stomach, intestine, or other region of the gastrointestinal tract, while affixing the tissue.


BACKGROUND OF THE INVENTION

In cases of severe obesity, patients may currently undergo several types of surgery either to tie off or staple portions of the large or small intestine or stomach, and/or to bypass portions of the same to reduce the amount of food desired by the patient, and the amount absorbed by the gastrointestinal tract. The procedures currently available include laparoscopic banding, where a device is used to “tie off” or constrict a portion of the stomach, vertical banded gastroplasty (VBG), or a more invasive surgical procedure known as a Roux-En-Y gastric bypass to effect permanent surgical reduction of the stomach's volume and subsequent bypass of the intestine.


Typically, these stomach reduction procedures are performed surgically through an open incision and staples or sutures are applied externally to the stomach or hollow body organ. Such procedures can also be performed laparoscopically, through the use of smaller incisions, or ports, through trocars and other specialized devices. In the case of laparoscopic banding, an adjustable band is placed around the proximal section of the stomach reaching from the lesser curve of the stomach around to the greater curve, thereby creating a constriction or “waist” in a vertical manner between the esophagus and the pylorus. During a VBG, a small pouch (approximately 20 cc in volume) is constructed by forming a vertical partition from the gastroesophageal junction to midway down the lesser curvature of the stomach by externally applying staples, and optionally dividing or resecting a portion of the stomach, followed by creation of a stoma at the outlet of the partition to prevent dilation of the outlet channel and restrict intake. In a Roux-En-Y gastric bypass, the stomach is surgically divided into a smaller upper pouch connected to the esophageal inflow, and a lower portion, detached from the upper pouch but still connected to the intestinal tract for purposes of secreting digestive juices. A resected portion of the small intestine is then anastomosed using an end-to-side anastomosis to the upper pouch, thereby bypassing the majority of the intestine and reducing absorption of caloric intake and causing rapid “dumping” of highly caloric or “junk foods”.


Although the outcome of these stomach reduction surgeries leads to patient weight loss because patients are physically forced to eat less due to the reduced size of their stomach, several limitations exist due to the invasiveness of the procedures, including time, use of general anesthesia, time and pain associated with the healing of the incisions, and other complications attendant to major surgery. In addition, these procedures are only available to a small segment of the obese population (morbid obesity, Body Mass Index ≧40) due to their complications, leaving patients who are considered obese or moderately obese with few, if any, interventional options.


In addition to surgical procedures, certain tools exist for approximating or otherwise securing tissue such as the stapling devices used in the above-described surgical procedures and others such as in the treatment of gastroesophageal reflux disease (GERD). These devices include the GIA® device (Gastrointestinal Anastomosis device manufactured by Ethicon Endosurgery, Inc. and a similar product by USSC), and certain clamping and stapling devices as described in U.S. Pat. Nos. 5,403,326; 5,571,116; 5,676,674; 5,897,562; 6,494,888; and 6,506,196 for methods and devices for fundoplication of the stomach to the esophagus for the treatment of gastroesophageal reflux disease (GERD). In addition, certain tools, such as those described in U.S. Pat. Nos. 5,788,715 and 5,947,983, detail an endoscopic suturing device that is inserted through an endoscope and placed at the site where the esophagus and the stomach meet. Vacuum is then applied to acquire the adjacent tissue, and a series of stitches are placed to create a pleat in the sphincter to reduce the backflow of acid from the stomach up through the esophagus. These devices can also be used transorally for the endoscopic treatment of esophageal varices (dilated blood vessels within the wall of the esophagus).


There is a need for improved devices and procedures. In addition, because of the invasiveness of most of the surgeries used to treat obesity and other gastric disorders such as GERD, and the limited success of others, there remains a need for improved devices and methods for more effective, less invasive hollow organ restriction procedures.


BRIEF SUMMARY OF THE INVENTION

A system for tissue approximation and fixation is described which may be used to approximate and/or tension at least one fold of tissue from within a hollow body organ, such as the stomach, esophageal junction, and other portions of the gastrointestinal tract. Generally, the devices of the system may be advanced in a minimally invasive manner within a patient's body, e.g., transorally, endoscopically, percutaneously, etc., to create one or several divisions or plications within the hollow body organ. Examples of placing and/or creating divisions or plications may be seen in further detail in U.S. Pat. No. 6,558,400; U.S. patent application Ser. No. 10/188,547 filed Jul. 2, 2002; and U.S. patent application Ser. No. 10/417,790 filed Apr. 16, 2003, each of which is incorporated herein by reference in its entirety. The system may comprise at least a tissue acquisition and folding device and a tissue stapling or fixation device, each of which may be used together as a single system.


The folder assembly may generally comprise, in part, a tissue acquisition assembly which may be used to initially acquire and/or approximate at least one fold of the tissue. The acquisition assembly may comprise a tensioning member and a pod member, each of which may be independently articulatable to form a first compact configuration and a second larger, expanded configuration. Each of the members may be connected to respective first and second actuation rods on the distal end of a yoke member, which connects the pod members to an elongate working body or shaft. The working body itself may be comprised of a plurality of aligned link members which are adapted to provide some flexibility to the working body and which defines a main lumen throughout a length of the working body as well as through the handle connected to a proximal end of the working body. Moreover, the working body may be covered by a sheath or a covering to enhance the lubricity of the shaft as well as to maintain the interior of the working body clear from body fluids and debris and seal the shaft to allow insufflation of the target organ. Various materials may be utilized for the sheath including various plastics, elastomers, latex, polyurethane, thermoplastics, e.g., PTFE, silicone, PVC, FEP, Tecoflex®, Pebax®, etc., so long as they are preferably biocompatible.


At least one of the members, such as the pod member, may additionally define a vacuum chamber or opening into which the tissue may be drawn within. The opening of the vacuum chamber may be slotted along a direction parallel to a longitudinal axis of the working body; alternatively, the opening may be defined a variety of shapes, e.g., oval, elliptical, etc., and furthermore may be offset such that it is defined transverse to the longitudinal axis of the working body. The distal end of the pod member may have a flexible and/or atraumatic tip such as a blunt, rounded, or “bullet” tip, made from any number of polymers to facilitate the guidance of the acquisition assembly into the hollow body organ without damaging tissue along the way. One example of a device utilizing two pod members is described in further detail in U.S. patent application Ser. No. 10/686,326 filed Oct. 14, 2003, which is commonly owned and is incorporated herein by reference in its entirety.


A guidewire may optionally be used with the folder assembly during initial deployment and positioning within the hollow body organ in a manner similar to a catheter for guiding the acquisition assembly to a predetermined position. The use of the guidewire may assist in initial placement of the device transorally, either through the main lumen of the device or it can also be exchanged through a lumen in the tip of the pod member. Both of the members may each be adapted to pivot on respective hinge members such that in a first compact configuration, the first and second pod members are immediately adjacent to one another. When desirably positioned within the hollow body organ, a vacuum force may be applied within a vacuum chamber defined within the pod member such that tissue enters within the vacuum chamber or opening. To assist in placement of the device, various indicators may be used. For instance, one or several indicators may be located directly on the device or indicators may be utilized with the device in relation to anatomical structures or landmarks. In one example, an orientation marker may be placed at a point on the distal portion of the device that is visible endoscopically and can be adjusted relative to structures such as the “z-line” of the gastroesophageal, i.e., the place where a change in color of the tissue from whitish (esophagus) to a salmon color (stomach) occurs delineating what is referred to as the squamocolumnar junction, i.e., the point where the lining changes from esophageal (squamous) to stomach (columnar). Then, in moving to a second expanded configuration, one or both of the tensioning member and/or the pod member may be translated via actuation rods into opposing radial directions from one another such that the tissue is drawn through the tensioning member by the pod member and approximated to create a fold of tissue. Once this tissue fold has been desirably created, the fixation assembly may be advanced distally through the main lumen of the folder assembly and positioned upon exiting the main lumen to become clamped directly over the folded tissue. It is also within the scope of this disclosure to actuate the members simultaneously, serially or singularly.


One or more vacuum tubes may be routed through the length, or a partial length, of the working body for communication with the pod member. The proximal ends of the vacuum tubes may be connected to one or more vacuum pumps. Furthermore, the vacuum tubes may utilize braided materials, e.g., stainless steel or superelastic materials such as Nickel-Titanium alloy, integrated throughout to prevent kinking or pinching of the tubes.


The fixation assembly comprises, in part, a manipulatable stapler assembly connected via a flexible shaft to a stapler handle. The stapler assembly itself generally comprises a staple cartridge housing within which one or more staples are housed. A corresponding anvil is positioned in apposition to the staple cartridge housing and may be used to provide a staple closure surface when tissue to be affixed is adequately positioned between the staple cartridge housing and the anvil. With the stapler assembly connected at the distal end of a flexible shaft, a handle is connected at the proximal end of the shaft. The handle itself may allow the surgeon or user to hold and manipulate the fixation assembly while articulating the stapler assembly between an open and closed configuration. Moreover, the configuration of the handle allows the surgeon or user to actuate the stapler assembly as well as deploy the staples from the staple cartridge housing.


In use, the fixation assembly may be advanced within the folder assembly main lumen with the fixation assembly configured in a closed configuration. To maintain an orientation, i.e., rotational stability, of the fixation assembly relative to the folder assembly and the approximated tissue, the fixation assembly may be configured to have a shape which is keyed to a cross-sectional area of the folder assembly main lumen. The keyed configuration helps to ensure that as the fixation assembly is advanced through the folder assembly, that the stapler assembly is optimally positioned to be clamped over the tissue for fixation.


When the stapler assembly is advanced and has exited the main lumen of the working body, the staple cartridge housing may be actuated into an open configuration when positioned between distally extending arm members of a yoke to receive the tissue folded between the pod members. The yoke arm members are configured such that when the stapler assembly is positioned therebetween, the stapler assembly is prevented from rotating or bending out of alignment for tissue affixation, i.e., the lateral stability of the stapler assembly is maintained relative to the yoke and the tissue. The stapler assembly may then be advanced distally over the folded tissue and clamped onto the tissue for deploying the staples. To avoid damaging tissue surrounding the acquisition assembly, one or several insertion indicators may be defined along a portion of flexible shaft of the fixation assembly, preferably near a proximal end of the shaft, to aid the user in knowing when the stapler assembly may be safely articulated while the fixation assembly is positioned within the working body, i.e., the longitudinal stability of the stapler assembly is maintained relative to the folder assembly. The indicators may be configured to align with a proximal end of the folder handle to correspondingly indicate, e.g., a position of the fixation assembly relative to the folder assembly when the stapler assembly may be opened, and/or how far distally the fixation assembly may be advanced relative to the folder assembly to engage the folded tissue, and when the devices are in a “safe to clamp” mode (e.g., in position around the tissue). Such positional indicators may utilize mechanical features, such as a stop or detent. In addition, the stapler assembly jaws my be spring-loaded open to assist insertion.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a perspective view of a tissue folding and fixation assembly which may be advanced within a hollow body organ to reconfigure the tissue from within.



FIGS. 2A and 2B show open and closed perspective views, respectively, of the tissue folding assembly, respectively, which may be used to manipulate tissue.



FIG. 3 shows a perspective view of one variation of the tissue folding assembly in which a guidewire may be used to facilitate deployment and/or placement within a body.



FIGS. 4A and 4B show side views of a variation of the tissue folding assembly in an open and closed configuration, respectively, where the members may be configured to maintain a parallel configuration relative to one another.



FIGS. 5A and 5B show open and closed perspective views, respectively, of another variation of the tissue folding assembly showing an attachment region.



FIG. 6 shows an end view of a closed tissue folding assembly.



FIG. 7 shows a perspective view illustrating in one variation how a stapler assembly may be advanced through the main lumen of the working body.



FIGS. 8A to 8C show cross-sectional side views of rotatable valves which may be used control the vacuum force within the device.



FIGS. 9A and 9B show an end view of an acquisition assembly which has been translated with respect to one another while adhering tissue.



FIG. 10A shows a partial assembly of the handle for the folder assembly.



FIG. 10B shows a detail view of an exploded assembly of anchoring mounts and a proximal portion of an actuation rod assembly.



FIG. 11 shows a side view of an alternative variation on a dual actuator folder assembly housing.



FIGS. 12A to 12C show side, end, and perspective views, respectively, of a link which may serve as a transitional link between the folder handle and the working body.



FIGS. 13A to 13C show side, end, and perspective views, respectively, of one variation of links which may be used to form at least part of the working body.



FIG. 13D shows an end view of a link having cross-sections of some of the various internal lumens which may be routed through the working body.



FIGS. 14A to 14C show side, end, and perspective views, respectively, of one variation of an end link which may be used as a terminal link of the working body.



FIG. 15 shows an end view of a link with the fixation assembly positioned within for advancement through the main lumen of the working body while maintaining a consistent orientation.



FIGS. 16A to 16C show top, cross-sectional side, and perspective views, respectively, of one variation of a yoke member.



FIGS. 17A and 17B show front and rear end views, respectively, of the yoke member of FIGS. 16A to 16C.



FIG. 18 shows a top view of a stapler cartridge assembly positioned between the arm members of the yoke.



FIGS. 19A and 19B show variations of the stapler assembly positioned between the yoke having varied open regions.



FIGS. 20A to 20C show top, end, and side views, respectively, of an alternative angled hinge member for use with a tensioning and/or pod member.



FIGS. 21A to 21C show top and perspective views, respectively, of a variation of a yoke and hinge assembly.



FIG. 22A shows a perspective view of one variation of a top cover which may be used with the acquisition assembly.



FIG. 22B shows a cross-sectional view of an optional basket insert positioned within a vacuum chamber and a top cover secured over the chamber.



FIGS. 23A and 23B show another variation of FIGS. 22A and 22B, respectively, where the top cover and/or pod member may have serrations.



FIGS. 24A to 24D show side, end, bottom, and perspective views, respectively, of an optional basket insert which may be placed within the vacuum chamber of the pod assembly.



FIGS. 25A and 25B show side views of a variation of the stapler assembly in clamped and opened configurations, respectively.



FIGS. 26A and 26B show side views of a variation of a cam member which may be used to urge the stapler assembly open and close.



FIGS. 27A to 27C show cross-sectional side, front, and top views, respectively, of one variation of stapler assembly.



FIG. 27D shows a top view of the anvil of the stapler assembly.



FIG. 28 shows a side view of another variation of a stapler assembly having serrations defined along its clamping surfaces.



FIG. 29A shows a top view of one variation of staple pushers positioned over corresponding staples.



FIG. 29B shows a detailed perspective view of one example of a staple pusher.



FIG. 29C shows a perspective view of one example of a wedge which may be configured to slide within the cartridge housing.



FIGS. 30A and 30B show cross-sectional side views of one variation of a stapler handle and its associated controls.



FIGS. 31A and 31B show perspective views of another variation of the approximation device having an actively or passively curved working body.



FIG. 31C shows a detail view of the actuation handle of the device in FIGS. 31A and 31B.



FIGS. 32A and 32B show perspective and end views, respectively, of a variation of an end cap or seal which may be used to cap the handle of FIG. 31C.



FIG. 33 shows a perspective view of one variation in which an endoscope can be retroflexed to view the results or progress of the tissue approximation and/or fixation.



FIG. 34 shows a portion of a flexible shaft of a stapler assembly with several insertion indicators positioned through the main lumen of the handle of the folder assembly.





DETAILED DESCRIPTION OF THE INVENTION

A system for tissue approximation and fixation is described which may be utilized for approximating tissue regions from within a hollow body organ, such as the stomach, esophageal junction, and other portions of the gastrointestinal tract. The system may be advanced within a body through a variety of methods, e.g., transorally, transanally, endoscopically, percutaneously, etc., to create one or several divisions or plications within the hollow body organ. At least two devices may be utilized as part of the system, a tissue acquisition and folding system and a tissue stapling or fixation system, although it is contemplated that both devices can be integrated into a single mechanism. Each of these devices may be configured to efficiently operate with one another to provide optimal methods and devices for at least acquiring, approximating, and stapling regions of tissue from within the hollow body organ in a minimally invasive manner.


Turning now to the figures, the system will first be described generally in which one variation of system 10 is shown in FIG. 1, which illustrates a perspective view of folder assembly 12 and fixation assembly 14. This system may be particularly useful in creating and approximating at least a single fold of tissue from within the hollow body organ. Such treatments may be effectuated for a variety of maladies; one particular malady in which such a system may be used is for the treatment of GERD. Folder assembly 12, which is described below in greater detail, may be comprised generally of acquisition assembly 16, which may be used to initially acquire and approximate the tissue to be folded. Acquisition assembly 16 may have a tensioning member 18 and a pod member 20, each of which may be independently articulatable to form a first compact configuration and a second larger, expanded configuration. Each of tensioning member 18 and pod member 20 may be connected to respective first and second actuation rods 22, 24 on the distal end of a yoke member 26, as described in further detail below.


Acquisition assembly 16 may be located at the distal end of working body 28 which may be configured as a flexible shaft having one or several lumens defined through the length of the working body 28. The working body 28 may be covered by a sheath or covering 30 to enhance the lubricity of the shaft as well as to maintain the interior of the body 28 clear from body fluids and debris and provide a seal to allow insufflation of the target organ. Various materials may be utilized for sheath 30 including various plastics, elastomers, latex, polyurethane, thermoplastics, e.g., PTFE, FEP, silicone, PVC, Tecoflex®, Pebax®, etc., so long as they are preferably biocompatible.


A number of vacuum tubes 32 may also be routed through the length, or a partial length, of the working body 28 to acquisition assembly 16. The figure shows vacuum tubes 32 entering the working body 28 at its proximal end. Alternatively, vacuum tubes 32 may enter working body 28 at some distal point along the length of body 28 or vacuum tubes 32 may enter working body 28 through handle 34. In either case, vacuum tubes 32 may be positioned within one or several lumens defined through working body 28 and placed in fluid communication with pod member 20 to facilitate in vacuum actuation of tissue, as further described below. The proximal ends of vacuum tubes 32 may be connected to one or more vacuum pumps (not shown). Furthermore, vacuum tubes 32 may utilize braided materials, e.g., stainless steel, superelastic materials such as Nickel-Titanium alloy, integrated throughout to prevent kinking or pinching of the tubes 32. Such vacuum tubes 32 may also accommodate insertion of a snare or grasper type device that can be inserted once tissue is acquired to mechanically grasp the invaginated tissue, depending on the type of tissue manipulation desired. An example of a “gooseneck” snare by Microvena, Inc. which may be used with the vacuum tubes 32 is described in further detail in U.S. Pat. No. 5,171,233, which is incorporated herein by reference in its entirety.


The proximal end of working body 28 is operatively connected to handle 34. Also connected to handle 34 are first and second actuators 36, 38 which may be used to actuate tensioning member 18 and pod member 20 from the first compact configuration to the second larger, expanded configuration. Each actuator 36, 38 may be actuated individually to control a corresponding member independently of the other member or may be actuated simultaneously, as described later herein. Main lumen 40 may be defined throughout the length of working body 28 and through handle 34 such that fixation assembly 14 may be advanced and withdrawn through the folder assembly 12. Fixation assembly 14 comprises, in part, stapler assembly 42 connected via flexible shaft 48 to a stapler handle 50. Stapler assembly 42 generally comprises staple cartridge 44, within which one or more staples are housed. Stapler assembly 42 may also have an optional tapered distal end to facilitate insertion of the device into or past tissue, as described in further detail below. Anvil 46 is in apposition to staple cartridge 44 and is used to provide a staple closure surface when tissue to be affixed is adequately positioned between staple cartridge 44 and anvil 46. With stapler assembly 42 connected at the distal end of flexible shaft 48, handle 50 is connected at the proximal end of shaft 48. Handle 50 may generally comprise a housing and grip 52 in apposition to actuation handle 54. Handle 50 allows for the surgeon or user to hold and manipulate fixation assembly 14 with grip 52 while articulating stapler assembly 42 between an open and close configuration via actuation handle 54. Moreover, the configuration of handle 50 allows the surgeon or user to articulate stapler assembly 42.


When fixation assembly 14 is advanced within folder assembly 12, stapler assembly 42 is preferably in a closed configuration. When stapler assembly 42 has exited working body 28, staple cartridge 44 may be articulated into an open configuration when positioned between yoke 26 to receive the tissue folded between tensioning member 18 and pod member 20. Stapler assembly 42 may then be advanced distally over the folded tissue and clamped close over the tissue for deploying the staples. To avoid damaging tissue surrounding acquisition assembly 16 and to facilitate proper stapling, one or several insertion indicator(s) 56 may be defined along a portion of flexible shaft 48 preferably near a proximal end of shaft 48, to aid the user in knowing when stapler assembly 42 may be safely articulated while fixation assembly 14 is positioned within working body 28. Indicators 56 may be configured to align with a proximal end of folder handle 34 to correspondingly indicate, e.g., a position of fixation assembly 14 relative to folder assembly 10 when stapler assembly 42 may be opened, and/or how far distally fixation assembly 14 may be advanced relative to folder assembly 10 to engage the folded tissue, etc. In addition to visual indicators, a mechanical indication, such as a stop or detent may be employed to give the operator a tactile indication of “safe to open” and “safe to clamp” device positions.


A brief description of the acquisition assembly 16 will be given in order to describe how the tissue may be manipulated by the devices described herein. A more detailed description will be given below. Perspective views of one variation of acquisition assembly 16 in an open and closed configuration are shown in FIGS. 2A and 2B, respectively. Tensioning member 18 may be comprised of tensioning arms 62, 64 which may extend longitudinally from a cross member. Each tensioning arm 62, 64 may be configured to extend in parallel with one another and may be equal in length, as shown. Alternatively, arms 62, 64 may be staggered in length and may also be angled relative to one another depending upon the desired approximated tissue configuration, as described in greater detail below. The distal ends of tensioning arms 62, 64 may be blunted or rounded to present an atraumatic surface to the tissue to be approximated.


The pod member 20 may be comprised of a vacuum chamber or opening 60 into which tissue may be drawn therewithin. A vacuum tube 76, as may be seen in FIG. 4A, leads to pod member 20. The opening of vacuum chamber 60 may be slotted along a direction parallel to a longitudinal axis of the working body 28, or may be transverse to the parallel axis; alternatively, the opening may be defined a variety of shapes, e.g., oval, elliptical, etc. One or both tensioning arms 62, 64 are preferably configured to be parallel with vacuum chamber 60 and may have a length equal to that of vacuum chamber 60. Alternatively, the lengths of tensioning arms 62, 64 may be less than or greater than that of vacuum chamber 60. The distal end of the pod member 20 may have a flexible and/or atraumatic tip 66 made from any number of polymers to facilitate the guidance of acquisition assembly 16 into the hollow body organ without damaging tissue along the way. The tensioning arms 62, 64 may form a tissue receiving region 90 between the arms 62, 64 through which tissue may be drawn and/or tensioned between the arms 62, 64.


In its compact configuration, tensioning member 18 and pod member 20 of acquisition assembly 16 may each be shaped to compactly fit with one another. For instance, in this variation, tensioning arms 62, 64 may be configured to become adjacently positioned on either side of vacuum chamber 60. In alternative variations, tensioning arms 62, 64 may be configured to move relative to one another to alter the area of tissue receiving region 90 between the arms 62, 64.


When tensioning member 18 and pod member 20 are actuated between an open configuration, as shown in FIG. 2A, and closed configuration, as shown in FIG. 2B, each of the members 18, 20 may be configured to maintain a parallel configuration relative to one another. Both tensioning member 18 and pod member 20 may each be adapted to pivot on respective hinge members 72, 74 such that in a first compact configuration, tensioning member 18 and pod member 20 may be immediately adjacent to one another. In moving to a second expanded configuration, tensioning member 18 with tensioning arms 62, 64 and pod member 20 may be translated via actuation rods 22, 24, respectively, into opposing radial directions from one another relative to yoke 26, as shown in FIG. 2A. With tensioning member 18 and pod member 20 in the open configuration, a tissue fixation region 92 may be defined between the members 18, 20, as further described below. FIGS. 4A and 4B show side views of an open and closed configuration, respectively, of the variation in which members 18, 20 may be configured to maintain a parallel configuration relative to one another. FIG. 4A shows members 18, 20 configured into an expanded configuration to define tissue fixation region 92 between the members, which are shown in this variation as being parallel to one another. FIG. 4B shows members 18, 20 configured into the smaller delivery configuration where each of the members 18, 20 are still parallel to one another.


A guidewire may optionally be used with the folder assembly 12 during initial deployment and positioning within the hollow body organ in a manner similar to a catheter for guiding acquisition assembly 16 to a predetermined position. Accordingly, an optional guidewire lumen may be defined in atraumatic tip 66. As seen in FIG. 3, guidewire lumen 68 may be defined through atraumatic tip 66 with guidewire 80 extending through from guidewire opening 70 to guidewire opening 78. Guidewire openings 70, 78 may both be defined on, e.g., atraumatic tip 66, to enable exchange of the guidewire through one or both tips; however, guidewire openings 70, 78 may also be defined on other regions of pod member 20 depending upon the type of exchange capability desired.



FIGS. 5A and 5B show tensioning member 18 and pod member 20 actuated between an open configuration and closed configuration, respectively, with the atraumatic tip 66 removed. The attachment region 94 may be used during deployment without any attachments upon the region 94. Alternatively, various other devices aside from an atraumatic tip 66 may be utilized for attachment to region 94. For example, components for use in drug delivery, dye marking, sensors for detecting various physical parameters, etc., may be utilized and attached onto region 94.



FIG. 6 shows an end view of the acquisition assembly 16 in a closed configuration. As seen in this particular variation, tensioning arms 62, 64 may be configured to align adjacently on either side of vacuum chamber 60 to form a compact configuration for delivery. Tensioning arms 62, 64 are shown as being flush with a surface of vacuum chamber 60, however, tensioning arms 62, 64 may be sized in a variety of different configurations and sizes as practicable for approximating tissue.



FIG. 7 shows a perspective view illustrating in one example how stapler assembly 42 may be advanced through the main lumen 40 of working body 28. Once tensioning member 18 and pod member 20 have been actuated into an open configuration (the approximated tissue is not shown for clarity), stapler assembly 42 may be advanced distally and manipulated such that staple cartridge 44, within which one or more staples are housed, and anvil 46 are in an open configuration ready to clamp over and fasten any approximated tissue which may be presented between tensioning member 18 and pod member 20 in fixation region 92.


The vacuum force which may be used to draw in the tissue within vacuum chamber 60 of pod member 20 may be controlled through a number of various methods. One variation is illustrated in FIGS. 8A to 8C, which show how valves 82 may be integrated into handle 34 for controlling the vacuum force. As seen in the cross-sectional side view of FIG. 8A, valve 82 may be configured to rotate and align such that vacuum lumen 84 comes into fluid communication with lumen 86, which leads to working body 28. Vacuum lumen 84 may be connected to a vacuum control unit (not shown), e.g., a standard luer assembly (QOSINA, model #99720), to allow for air to be drawn through lumen 86 and create the vacuum at the distally-located pod members. FIG. 8B shows how valve 82 may be rotated by some degree, e.g., 45° relative to a longitudinal axis of handle 34, such that the vacuum force is no longer in fluid communication with lumen 86. FIG. 8C shows how valve 82 may be further rotated, e.g., 90° relative to a longitudinal axis of handle 34, such that lumen 86 is in fluid communication with venting lumen 88 to allow for venting of the assembly. A second valve, as shown, may be integrated in handle 34 to allow for the independent control of the vacuum force in a second optional pod member. Vacuum lumen 84 may be fluidly connected to a common or independent vacuum pump. Moreover, rather than having two independently controllable valves 82, a single valve 82 may be utilized to control the vacuum force in the pod member 20, depending upon the desired results. The above variations are intended to be illustrative and are not intended to be limiting in their scope of the disclosure in the various possible configurations and methods available for controlling the vacuum force.



FIGS. 9A and 9B show the movement of tensioning member 18 and pod member 20 relative to one another in reconfiguring the surrounding tissue. FIG. 9A shows an end view of tensioning member 18 and pod member 20 which have been advanced while in a closed configuration into, e.g., a stomach, and positioned adjacent to a region of interior tissue to be reconfigured. When desirably positioned, a vacuum force may be applied within vacuum chamber 60 of pod member 20 such that tissue enters within the vacuum chamber or opening 60.


The different linings of the stomach, which include the mucosal layer MUC, muscular layer ML, and serosal layer SL, are shown in cross-section. The vacuum force may be applied such that at least the mucosal layer MUC of the tissue, e.g., an anterior wall AW and posterior wall PW, is drawn into vacuum chamber 60 and the tissue is sufficiently adhered to the pod member 20. While the vacuum force is applied, tensioning member 18 and pod member 20 may be translated away from one another in opposing direction such that the adhered tissue is drawn between the tensioning arms 62, 64 of tensioning member 18 and pod member 20 such that at least two adjacent folds of tissue are created to form an overlap region of tissue, as shown in FIG. 9B. Alternatively, rather than having both tensioning member 18 and pod member 20 move opposite to one another simultaneously, one member may be held stationary while the other member is translated radially. In another alternative, pod member 20 may acquire the tissue and tensioning member 18 may be first translated and then pod member 20 may be subsequently translated as a separate step to enhance tissue acquisition and positioning. After the tissue has been acquired through any of the methods described above, the device may be curved or manipulated, as described in further detail below. The tissue may then be affixed through one of the methods as described herein.


The methods described herein in acquiring a single, longitudinal fold, may be particularly effective for use in treatments such as GERD or to exclude certain portions of the wall of the body organ. In addition, the device can assist in the placement or revision (e.g. as a secondary operation or secondary step in a single procedure) of certain surgical procedures, such as a Roux En Y gastric bypass, or vertical banded gastroplasty, or other restrictive procedures where the resulting pouch may be stretched over time and may need further reduction. Further, certain procedures can lead to unforeseen results such as the formation of a gastric/gastric fistula. Such a fistula may be closed with the devices and methods described herein. In a further example, the efficacy of the placement of a series of sutures or staples to form what is typically referred to as a “Collis” procedure, may be enhanced by the addition of a tissue fold at the outlet of the “Collis” geometry, in the vicinity of the pylorus, or at any point along the resulting geometry to create resistance to food intake or enhance food dwell time in the gastric region. Examples of other treatments are described in further detail in co-pending U.S. patent application Ser. No. 10/417,790, which has been incorporated by reference above. When the single tissue overlap is created by folder assembly 12, the overlap preferably includes an overlap of at least the muscular layer ML and serosal layer SL to ensure a secure anchoring platform for the staples or fasteners to maintain the durability of the tissue overlap. Such an overlap can also serve as a way for securing an additional item within the organ such as pacing leads, sensors (e.g. monitoring of stretch receptors within the stomach), monitors, or other such diagnostic or therapeutic devices, including but not limited to those described in U.S. patent application Ser. No. 10/215,070 filed Aug. 7, 2002, which is incorporated herein by reference in its entirety. A more detailed discussion may be found in U.S. patent application Ser. No. 10/188,547 filed Jul. 2, 2002, which is incorporated herein by reference in its entirety.


Folder Assembly


Folder assembly 12 may typically comprise a handle 34 at a proximal end of the assembly 12, as described above. Handle 34 may comprise housing 110 which may enclose a pod actuation assembly within. FIG. 10A shows a partial assembly of handle 34 to illustrate the internal mechanisms. As described above, first actuator 36 may be used to manipulate tensioning member 18 from a first configuration to a second configuration. Manipulation may be achieved, in part, by having first actuator 36 connected via shaft 112 to transmit a torquing force to threaded carriage shaft 114. The carriage shaft 114 is preferably free-floating, i.e., can translate longitudinally inside the shaft 112. Proximal mount 116 may be free to rotate about the carriage shaft 114, but it is preferably constrained to inhibit translation of mount 116 relative to the carriage shaft 114. Distal mount 118 may be slidingly positioned over carriage shaft 114, typically by a threaded connection. This threaded connection maintains a fixed relative distance between the mounts so that the mounts and the carriage shaft 114 may translate longitudinally as a unit. Proximal mount 116 and distal mount 118 may be anchored to the proximal ends of the actuation rod and tubing member, which houses the actuation rod, as described further below. Each mount 116, 118 and shaft 112 may be configured to be free-floating, i.e., translate longitudinally unconstrained, inside of shaft 112 within first actuation channel 120 to accommodate the lateral movement of working body 28 and the subsequent translational movement of the proximal ends of actuation rods within housing 110. Stop 144, e.g., a ring or shoulder defined upon shaft 114, may be positioned proximally of mount 116 to prevent the longitudinal movement of mount 116 along shaft 114. Mounts 116, 118, however, may be configured to maintain a fixed distance relative to one another when longitudinally translated as a unit. Corresponding mounts may be configured to translate along a second shaft (not shown) within second actuation channel 122 for a second actuation rod. Mounts 116, 118 may thus translate as a unit until actuator 36 is rotated.


The handle mechanism 34 helps to ensure that relative or unwanted movement of the pods during flexing of the shaft of the folder in minimized or eliminated. Additionally, tubes 136, as further described below, function so that the shaft of the device is not loaded during actuation. These tubes 136 help to support the actuation load, but still allow sufficient shaft flexibility.


As shown in FIG. 10B, which is a detail view of an exploded assembly of mounts 116, 118 and their corresponding actuation rod assembly. Proximal mount 116 may have a rod anchoring region 130 defined along one side and distal mount 118 may have tubing anchoring region 132 defined along one side and collinearly with rod anchoring region 130. Actuation rod 140 may be slidingly positioned within tubing member 136 and configured to slide longitudinally therewithin when translated relative to tubing member 136 for actuating a pod member. Actuation rod 140 may be anchored to proximal mount 116 by securely positioning actuation rod anchor 142 within anchoring region 130. Likewise, tubing member 136 may be anchored to distal mount 118 by positioning tubing anchor 138 within tubing anchoring region 132. Each mount 116, 118 may have collinearly defined openings 134 to accommodate rod tubing 136 and actuation rod 140 when they are secured within anchoring regions 130, 132. As actuator 36 is rotated, carriage shaft 114 is rotated about its longitudinal axis to urge mount 118 towards or away from mount 116, as shown by the arrows, depending upon which direction carriage shaft 114 is rotated. When mounts 116, 118 are urged towards one another, actuation rod 140 is forced to slide distally within and relative to tubing 136 to urge the pod member, e.g., into its expanded configuration. Similarly, when mounts 116, 118 are urged away from one another, actuation rod 140 is forced to slide proximally within and relative to tubing 136 to urge the pod member, e.g., into its compact configuration.


As further seen in FIG. 10A, main lumen 40 may be defined through a length of housing 110 to accommodate insertion of the fixation assembly 14 therethrough. The proximal opening 128 of lumen 40 may be gasketed to allow for the insufflation of the hollow body organ using the device as well as to prevent the leakage of bodily fluids and particles. Distal opening 124 may likewise be gasketed and is further configured to accept a proximal end of working body 28. The individual links 126 of one variation of the proximal end of working body 28 are shown in the figure to illustrate an example of the mating between working body 28 and housing 110.


An alternative variation on the folder assembly housing is shown in dual actuator assembly 150 in FIG. 11. In this variation, a side view of housing 152 is seen in which a single actuator or lever 158 may be utilized to manipulate both tensioning member 18 and pod member 20 simultaneously. Lever 158 may be configured to rotate about pivot 160 to urge actuation link 162 to translate within actuation slot 164 to simultaneously manipulate both members rather than having two or more separate controls. The proximal end of working body 154 may be seen connected to housing 152 and vacuum tube 156 may be seen leading into working body 154 for communication with the folder assembly.


When lever 158 is depressed, actuation link 162 translates proximal linkage 155 within actuation slot 164. Proximal linkage 155 is free to rotate about a pivot during flexure of the working body 154 and actuates proximal blocks 153 to slide longitudinally within channels 151, which are defined through housing 152. A spring or biased element 168 may be positioned within slot 164 to place a biasing force on link 162 and lever 158 such that the assembly maintains a neutral or fixed orientation, if desired. Proximal blocks 153 are connected to actuation rods 157 which may extend distally through distal blocks 159 and further into working body 154. Distal blocks 159 may be pivotally connected to distal linkage 163, which may be pivotally affixed to housing 152 via pivot 166 while allowing distal blocks 159 to translate within channels 151. Tubing members 161 may be configured to allow passage of actuation rods 157 therethrough while remaining connected to distal blocks 159. Although the specific configuration of this variation is shown and described, this is not intended to be limiting and is illustrative of one variation of a handle which allows for single activation and tunable mechanical advantage.


The working body 28, which extends between the handle and the pod assembly located at the distal end of the working body 28, may be comprised of a plurality of links or knuckles generally cylindrical in shape and positioned adjacently to one another, as shown and described above in FIG. 10A. A transition link or knuckle 170 is shown in FIGS. 12A to 12C, which show side, end, and perspective views, respectively, of a link which may serve as a transitional link between the handle and the length of the working body 28. As seen in the side view of FIG. 12A, transition link 170 may have a proximally located cylindrically-shaped flange 172 with a diameter greater than a diameter of the body portion 176. Flange 172 may serve to help anchor the working body 28 to the handle by fitting within a cavity defined in the handle and shaped to receive flange 172. A transition portion 174 may taper a region of the link 170 down to body portion 176. The end view in FIG. 12B shows main lumen 178 defined through the length of link 170. Main lumen 178 may be shaped with parallel sides opposite to one another to allow fixation assembly therethrough in a specified configuration, as described below in further detail.


Although the transition link 170 is shown to be generally cylindrical in shape, it may alternatively be configured in a variety of shapes, e.g., ovular, elliptical, etc. Transition link 170 may also range in diameter, e.g., 0.75 in. (about 1.90 cm), so long as it is wide enough to accommodate the insertion of fixation assembly 14 therethrough yet small enough to be inserted into the body, e.g., through the esophagus. Link 170 may also range in length, e.g., 1.125 in. (about 2.85 cm), depending upon the desired design characteristics. Moreover, transition link 170 may be made from a variety of materials, e.g., metals, plastics, etc., so long as it is biocompatible. For example, transition link 170 may be made from stainless steel, nickel-titanium alloys, or it may be molded from plastics and thermoplastics, e.g., polycarbonate resins such as Makrolon® (Bayer Aktiengesellschaft, Germany).



FIGS. 13A to 13C show side, end, and perspective views, respectively, of an example of a knuckle or link 180 which may be used to form at least part of the working body 28. This link variation 180 may be made from a material similar to that of transition link 170. It may also range in diameter, e.g., 0.69 in. (about 1.75 cm), so long as link 180 is wide enough to accommodate the insertion of fixation assembly 14 therethrough yet small enough to be inserted into the body, as above. Lumen 182 may be configured such that it is keyed to allow fixation assembly 14 to pass through in a specified configuration; thus, in this particular variation, lumen 182 is shown as having straight walls 196, which may be parallel and opposite to one another. Link 180 may also define one or more routing channels 184 around the circumference of the link 180 to allow for the routing of various wires or tubes therethrough along a length of working body 28. Link 180 shows a variation in which two routing channels 184 may be defined on opposing sides around the circumference. As further seen in FIG. 13A, link 180 may further define peripherally located actuator rod lumens 196 and additional routing lumens 188 in link 180 outside of lumen 182. This variation shows at least two of each lumen 186, 188 defined on opposing sides of link 180, although they may be defined elsewhere around link 180 in other variations depending upon the number of lumens desired as well as spacing considerations.



FIG. 13B shows a side view of link 180 having least two protrusions 190 extending from a first surface 192 on either side of the periphery of link 180. Protrusions 190 may extend from first surface 192 at a distance, e.g., 0.040 in. (about 0.10 cm), so that when multiple links are aligned with one another, protrusions 190 abut the second surface 194 of an adjacent link, as shown in FIG. 13C. When multiple links are aligned, lumen 182, as well as actuator rod lumen 186 and additional routing lumen 188 may be aligned with adjacent links to form the overall main lumen 40 and actuator rod lumen, as described above. Alternatively, overall flexibility of the device may be achieved by a single structure that contains axial slots along its length, such as that shown in U.S. Pat. No. 5,685,868, which is incorporated herein by reference in its entirety. Similarly, the working body may be formed of a single piece, flexible component, such as a polymer extrusion and/or multi-lumen co-extruded design, a braid, or other such known materials.



FIG. 13D shows an end view of link 180 in one variation where actuation rod 198 is routed through actuator tubing member 202 and both may be disposed within actuator rod lumen 186 such that both extend through a length of working body 28. Vacuum tubes 200 may also be positioned within routing channels 184 and the entire assembly may be covered by sheath or lining 204, which may extend along at least a portion of working body 28, and preferably over the entire length of working body 28. If a single pod member 20 having a vacuum chamber 60 is utilized, one of the two vacuum tubes 200 may be utilized. Alternatively, a second vacuum tube 200 may also be utilized if the tensioning member 18 were configured with openings for allowing a vacuum to be created therethrough or if a second pod member were utilized. Sheath or lining 204, as mentioned above, may be used to enhance the lubricity of the working body 28 as well as to maintain the interior of the body 28 clear from body fluids and debris and to provide sealing to enable insufflation of the target area. Various materials may be utilized for sheath 204 including various plastics, elastomers, latex, polyurethane, thermoplastics, e.g., PTFE, silicone, PVC, FEP, Tecoflex®, Pebax®, etc., so long as they are preferably biocompatible. Moreover, sheath 204 may also utilize braided materials integrated throughout to increase tensile, compressive, and/or torsional strengths of sheath 204 as well as to provide for resistance against kinking or pinching between individual links or when working body 28 is flexed.



FIGS. 14A to 14C show side, end, and perspective views, respectively, of one variation of end link 210, which may be utilized as the terminal or final link of working body 28. End link 210, much like links 180, may define a keyed lumen 212, routing lumens 214, and actuator rod lumen 218. Lumen 216 may also be defined and it may be counterbored to accommodate a mechanical fastener for connecting the yoke member. As the terminal link, actuator tubing member 202 may be terminated and attached to end link 210 at lumen 218 while allowing the actuator rod to extend through and beyond lumen 218 for attachment to the pod assembly. Side and perspective views in FIGS. 14B and 14C further show detent 222, which may be defined along the end surface of link 210 for receiving and/or engaging the yoke member. Moreover, end link 210 may be made from the same or similar materials as described above for the other links. However, end link 210 is preferably made from a material such as a metal, e.g., stainless steel, or polycarbonate, which may withstand forces generated during pod and tissue manipulation. The end link 210, or a similar or additional link, may also be used to terminate any covering placed over the working body 28 as heretofore described in FIG. 13D.



FIG. 15 shows an end view of link 180 with staple cartridge 44 and anvil 46 of fixation assembly 14 positioned within lumen 182 for advancement through working body 28. As seen, lumen 182 may be configured such that it is keyed to allow fixation assembly 14 to pass through in a specified orientation. Walls 196, which may be parallel and opposite to one another, may thus be sized and configured to prevent fixation assembly 14 from rotating about its own longitudinal axis within lumen 182 during advancement and deployment from the main lumen. Maintaining fixation assembly 14 in a predetermined orientation relative to working body 28 and pod assembly 16 also helps to ensure that when staple cartridge 44 and/or anvil 46 are actuated to open for clamping over folded tissue, a known orientation of fixation assembly 14 relative to the folded tissue is maintained for tissue fixation. Other configurations for keying lumen 182 to fixation assembly 14 may be available in other variations; the shape of lumen 182 and the cross-sectional shape of fixation assembly 14 are not intended to be limiting but are merely illustrative of one possibility of creating and/or configuring a keyed orientation between the two assemblies.


A yoke member may be positioned at the terminal end of working body 28 for holding and maintaining pod assembly 16. FIGS. 16A to 16C show top, cross-sectional side, and perspective views, respectively, of yoke 230. Generally, yoke 230 may be comprised of first arm member 232 and second arm member 234 extending in parallel to one another from a base member 242, which may be attached via proximal surface 244 to end link 210 of working body 28. Yoke 230 may terminate at each arm member 232, 234 in first and second pivot regions 236, 238, respectively, about which the pod assembly 16 may be manipulated. First and second arm members 232, 234 may further extend longitudinally with an overall length of about, e.g., 2 in. (about 5 cm), to create open region 240 between the arm members 232, 234. First and second arm members 232, 234 may also be tapered along their lengths to facilitate insertion of yoke 230 within a tissue region. The opposing sides of each arm member 232, 234, which in part defines open region 240, may be parallel to one another and are spaced apart, e.g., at 0.40 in. (about 1.0 cm), to provide clearance for stapler assembly 42 to be advanced therethrough. Furthermore, the open sides of region 240 may provide adequate clearance for stapler assembly 42 to be opened for advancement over tissue to be affixed while arm members 232, 234 help to maintain the orientation of stapler assembly 42 relative to yoke 230 and working body 28.


The actuation rods for manipulating acquisition assembly 16 may extend through yoke 230 via first and second actuation rod channels 246, 248, which may be seen in the perspective view of yoke 230 in FIG. 16C. A portion of actuation rod channels 246, 248 may be slotted or grooved and open along an outer surface of each of arm members 232, 234 to allow actuation rods to extend past the outer surface during pod manipulation. FIGS. 17A and 17B show front and rear end views, respectively, of yoke 230 to provide a detail view of actuation rod channels 246, 248 and open region 240.


As mentioned above and as shown in the top view of stapler cartridge/yoke assembly 250 in FIG. 18, each arm member 232, 234 may be parallel to one another and spaced apart to provide clearance for stapler assembly 42 to be advanced therethrough. The arm members 232, 234 may function as guide surfaces 252, 254, respectively, to maintain stapler assembly 42 oriented in a predetermined configuration relative to yoke 230. Furthermore, open region 240 may provide adequate clearance for stapler assembly 42 to be opened prior to advancement over tissue while guide surfaces 252, 254 help to maintain the orientation of stapler assembly 42 relative to yoke 230 and working body 28. Additionally, as shown in FIG. 18, clearance slots (open region 240) may function to provide clearance for an endoscope or other tool, that can be inserted and advanced or retroflexed to view the working device, as shown below in further detail.


To assist in alignment of the stapler assembly 42 to the target tissue, it may be desirable to vary the length of the open region 240. As further shown in FIG. 19A, open region 240 may be configured with a stop, cover, or extension 256 located adjacent to anvil 253 to constrain any transverse or lateral movement of anvil 253 while facilitating movement of cartridge assembly 251. Alternatively, if anvil 253′ is configured to move, stop or extension 258 may be configured adjacent to cartridge assembly 251′ to constrain any transverse or lateral movement of cartridge assembly 251′ while facilitating movement of anvil 253′, as shown in FIG. 19B.


From the distal end of each arm member 232, 234 of yoke member 230, a hinge member may be connected pivotally and extend distally where it may be again pivotally connected to a pod member. An alternative angled hinge member 260 may be seen in FIGS. 20A to 20C, which show top, end, and side views, respectively. Angled hinge 260 may have a proximal portion 262 connected to a distal portion 264, which may be angled with respect to either or both side surface 270 and top surface 272 of proximal portion 262. A yoke-hinge pivot 266 may be defined at a proximal end of proximal portion 262 for pivotal connection to first pivot 236 located on yoke 230. Similarly, a hinge-pod pivot 268 may be defined at a distal end of distal portion 264 for pivotal connection to a pod member. Additionally, actuator rod channel 274 may be optionally defined along at least a portion of proximal portion 262 to provide an opening or space for placement of an actuator rod. A second hinge member, which may mirror the configuration of angled hinge 260, may be configured for connection to second hinge 238 of yoke 230 for connection to tensioning member 18. Moreover, angled hinge member 260 may be made from any variety of metals or thermoplastics, as described above.


Alternatively, a variation of a yoke/hinge assembly 280 may be utilized, as shown in the top views of FIGS. 21A and 21B. In this variation, yoke/hinge assembly 280 may be configured to flex via one or several additional pivots along its length. Additional ramp members 286, 286′, 290, 290′, which may be extension members of yoke 282 having pivoted regions at both proximal and distal ends, may be joined via pivots 284, 284′, 288, 288′, respectively, to one another to form elongated arms. Hinge members 294, 294′ may be connected via pivots 292, 292′, respectively, to ramp members 290, 290′, respectively, and have pivots 296, 296′ located at their distal ends for connection to tensioning member 18 and pod member 20.


Hinge members 294, 294′ may be actuated to an expanded configuration, as shown in FIG. 21A, and yoke/hinge assembly 280 may also be configured to flex via tensioning members (not shown) positioned within a lumen or slot defined along the length of assembly 280 in one or both arms. These tensioning members may be actively manipulated by the user from their proximal ends. Thus, assembly 280 may be flexed to have a bend radius, as shown in the example of FIG. 21B, to allow access to various regions within the hollow body organ as well as to affix various configurations of tissue. Alternatively, assembly 280 may also be passively flexed by contact against tissue or via an external device, such as a mandrel, a gripping tool, or endoscopes configured to flex the assembly 280. FIG. 21C shows an example of a compact configuration of assembly 280 which may be utilized for deployment within a body.


In another variation, the folder assembly 12 may include a hinge device adapted to actively angle the acquisition assembly 16 in an offset configuration. For example, the acquisition assembly 16 may be actuated to rotate the tensioning member 18 and pod member 20 about respective pivots such that the members 18, 20 may be offset at an angle, α, relative to a longitudinal axis of the working body 28. From this offset configuration, tissue may be approximated and affixed at various angles. Alternatively, members 18, 20 may also be configured to be passively flexed by contact against tissue or via an external device, including any of the tools described above. Furthermore, both members 18, 20 may also be offset at various angles depending upon the desired tissue configuration; moreover, each pod member may be also independently offset at its own angle, again depending upon the tissue configuration. These examples are merely intended to be illustrative and are not intended to be limiting.


A top cover 372 which defines opening 374, as shown in FIG. 22A, may be secured over the vacuum chamber in pod member 20. An undercut 358 may be defined around opening 374 to help aid in mechanically adhering any tissue which may be drawn into opening 374. Opening 374 is shown as being slotted; however, it may be formed into an elliptical shape or various other shapes so long as an adequate opening is available for adhering a sufficient amount of tissue therewithin or thereto. Alternatively, rather than a single opening 374, multiple smaller openings may be defined over top cover 372 so long as an adequate area is available for adhering tissue thereto. An optional mesh-like insert may be positioned within vacuum chamber 340 to help prevent the vacuum chamber from becoming clogged by tissue.


Turning to FIGS. 24A to 24D, an optional basket insert 360 is shown in side, end, bottom, and perspective views, respectively. Basket insert 360 may be placed within the vacuum chamber to provide for an optimized mesh surface through which a vacuum force may be applied to the tissue. Overall dimensions of basket insert 360 may vary so long as it may be securely positioned within the vacuum chamber. An example of insert 360 dimensions is 1.3 in. (about 3.3 cm) in length and 0.3 in. (about 0.8 cm) in width. Basket insert 360 may also be made from a variety of materials, e.g., stainless steel, provided that the tensile strength is sufficient to withstand the various forces generated.


Basket insert 360 may have basket walls 362 forming a mesh-like vacuum chamber 370 with flange 364 surrounding the edges of one open side of insert 360. Each of the basket walls 362 may define a plurality of openings therethrough and the bottom surface of basket walls 362 may also define a plurality of supports 366 positioned in-between openings 368. These supports 366 may be configured to space each of the basket walls 362 away from the walls of vacuum chamber 340, as shown in FIG. 22B, which shows a cross-sectional view of basket insert 360 positioned within vacuum chamber 340 and top cover 372 placed over the chamber 340. Plenum 376 may thus be defined around the entire basket insert 360, or a portion thereof, between basket walls 362 and vacuum chamber 340 via the spacing provided by supports 366 and flange 364. The open plenum 376 allows a vacuum force to be applied to the tissue while preventing the tissue from clogging the vacuum chamber 340.


Alternatively, rather than utilizing a separate basket insert 360 for placement within vacuum chamber 340, the interior surface of vacuum chamber 340 may be textured, channeled, labyrinthed, or interdigitated to increase the surface area for vacuum adherence in the same manner as basket insert 360. Moreover, mechanical tines or teeth may be formed within basket insert 360 or within vacuum chamber 340 to facilitate additional mechanical adherence of tissue within the pod member. Another alternative may utilize a snare-like wire or member positioned within vacuum chamber 340 around opening 374. In such a variation, once tissue has been drawn through opening 374, the snare may be drawn tightly around the adhered tissue.


Moreover, one or both pod members may also incorporate a number of other methods to facilitate tissue movement and/or adherence to the respective pod member. For instance, FIGS. 23A and 23B show the top cover 372 and cross-sectional view of basket insert 360, respectively, of FIGS. 22A and 22B with the addition of serrations 341. These serrations 341 are shown as being defined along a length of cover 372; however, they may alternatively be defined around the opening 374 or in a number of various other configurations depending upon the desired results. Furthermore, serrations 341 are illustrated as protrusions but any variations or configurations of serrations 341 may also be utilized in other variations of the device.


Fixation Assembly


The fixation assembly, as mentioned above, may be delivered through the main lumen of the folder assembly for deployment over tissue which has been approximated into a folded configuration. One variation of a stapler which may be used with the folder assembly described herein is described in detail in U.S. Pat. No. 4,610,383 (Rothfuss et al.), which is incorporated herein by reference in its entirety. Another variation of a stapler assembly 390, which is positioned at the distal end of the fixation assembly, is shown in side views in FIGS. 25A and 25B. Generally, stapler cartridge 392 may be pivotally connected via pivot 396 to the end of flexible shaft 398. Anvil 394 may be configured to remain stationary relative to flexible shaft 398 while stapler cartridge 392 may be manipulatable into an open and closed configuration with respect to flexible shaft 398 and anvil 394. As seen, stapler cartridge 392 and/or anvil 394 may optionally incorporate a tapered end 411 positioned at a distal end of either cartridge 392, anvil 394, or both. Tapered end 411 may be fabricated of any of the polymers or other materials described herein and is preferably atraumatic to facilitate dilation or insertion past tissue. To manipulate stapler cartridge 392 to open and close, a circular or disk-shaped cam 400 may be pivotally attached about rotational pivot 402 located on the side of the proximal end of stapler cartridge 392. As seen in the detail view of cam 400 in FIG. 26A, actuation wires or cables 404, 406 may be wound about cam 400 such that when cable 404 is pulled, cam 400 is urged to rotate about rotational pivot 402 in the direction of arrow 408. Actuation cables 404, 406 may be manipulated from their proximal ends by the user. As cam 400 is rotated in direction 408, a portion of anvil 394 may be engaged by cam 400 thereby forcing stapler cartridge 392 to pivot into an open configuration, as shown in FIG. 25B, when cam 400 is fully rotated, as in FIG. 26B. Cam 400 may be made into other shapes, e.g., oval, elliptical, etc., depending upon the desired design characteristics. One cam 400 may be utilized, as shown; however, an additional cam may also be affixed on the opposite side of stapler cartridge 392 such that dual cams are configured to open and close simultaneously in parallel. Alternatively, in the same device, the location of stapler cartridge 392 and anvil 394 may be reversed (e.g. anvil 394 may be configured to move toward cartridge 392) depending on the location of the desired target and clearance desired.


Detail views of the stapler assembly is shown in FIGS. 27A to 27D. FIGS. 27A to 27C show cross-sectional side, front, and top views, respectively, of stapler assembly 410. Cartridge housing 412 generally houses a plurality of staples 414 which may be aligned adjacently to one another in one or more rows. The distal ends of both cartridge housing 412 and anvil 422 may be configured to be atraumatic, e.g., blunted, rounded, etc., to the tissue to be affixed. Moreover, cartridge housing 412 and anvil 422 may be configured such that their cross-sectional shape is keyed to the main lumen of the folder assembly so that the orientation of the cartridge housing 412 is maintained relative to the folder assembly, as described above.



FIG. 27C shows a top view of cartridge housing 412 wherein four rows of staples 414 may be aligned. Other variations of cartridge housing 412 may utilize fewer or greater than four rows of staples 414. To deploy staples 414 from cartridge housing 412, two wedges 416, 416′, which may be offset or staggered from one another, may each be pulled proximally through cartridge housing 412 via staple actuation wire 420. Wedges 416, 416′ may be adjacently positioned to one another but are preferably staggered such that the staples are deployed in a sequenced deployment order. Staple actuation wire 420 may be manipulated via its proximal end by the user when staples 414 are to be deployed out of cartridge housing 412 into the tissue.


Staples 414 may be deployed through staple apertures 418 defined over the surface of cartridge housing 412 in apposition to staple closure surface 424 of anvil 422. As the staggered wedges 416, 416′ are pulled proximally, each wedge 416, 416′ may engage one or more rows of staples and urge them through staple apertures 418, as shown in FIG. 27A, and through the tissue until they are engaged in corresponding staple detents 426, as shown in FIG. 27D. As further shown in FIG. 27D, which shows a top view of staple closure surface 424 of anvil 422, each staple detent 426 preferably corresponds to the distal ends of each staple 414.


As described above, cartridge housing 412 and/or anvil 422 may be configured to be atraumatic, e.g., blunted, rounded, etc.; however, it may be desirable to serrate or otherwise roughen the outside edges of both or either the cartridge 412 and/or anvil 422 to ensure full tissue capture upon clamping of the two surfaces. A variation of the stapler assembly 410 is shown in FIG. 28, which shows serrations 428 defined along the lengths of cartridge 412 and anvil 422. Serrations 428 may be optionally defined along only one of cartridge 412 or anvil 422 and it may also be defined only partially along the length. Alternatively, other projections or protrusions, such as spears, may be utilized. In yet another alternative, rather than utilizing projections or serrations 428, the surfaces of cartridge 412 and/or anvil 422 in contact with the tissue may simply be roughened or sharpened to facilitate serrating or roughening the contacted tissue or may employ absorptive materials in the form of pads, coatings or covers to facilitate traction. Such pads, covers or coatings may be formed of cotton, Goretex®, polyester, Velcro, (see in particular Seamguard™ product (W. L. Gore and Associates, Flagstaff, Ariz.)), etc., and may remain on the surface of the cartridge once staples are delivery, or alternatively may be transmitted with the staples to remain with the tissue affixed thereby.


To facilitate the deployment of the staples 414 as wedges 416, 416′ are urged through cartridge housing 412, staple pushers 430 may be utilized. As shown in FIG. 29A, which is a top view of one variation of staple pushers 430 positioned over corresponding staples 414, a single staple pusher 430 may be configured to engage two staples 414 in adjacent rows. When a wedge contacts a staple pusher 430, two adjacent staples 414 may be fired sequentially. FIG. 29B shows a detailed perspective view of one example of a staple pusher 430. In this variation, staple pusher 430 may be comprised of one or more sloped cam surfaces 432, 434 for slidingly engaging a wedge. As a wedge engages a cam surface, it may push staple pusher 430 down towards staples 414 as pusher 430 is guided via one or more guides 436, 438. Staple pusher 430 may then engage a first staple via staple engagement surface 440 and a second staple via staple engagement surface 442. An example of a wedge 446 which may be configured to slide within cartridge housing 412 is shown in the perspective view of wedge platform 444 in FIG. 29C. Although a single wedge 446 is shown in the figure extending from platform 444, two offset wedges may be configured into a single platform or two individual wedges may be utilized adjacent and offset to one another.


As mentioned above, cartridge housing 412 may be manipulated into an open and closed position for clamping over the tissue. To control the closure of cartridge housing 412 against anvil 422, a stapler control handle may be used, as shown in the cross-sectional views of the stapler control in FIGS. 30A and 30B. FIG. 30A shows stapler handle housing 450 which may house the tensioning and releasing mechanism for opening and closing cartridge housing 412 relative to anvil 422. Grip 452 may be provided for the user to grasp while manipulating the device during insertion and deployment as well as to help articulate actuation handle 454 for opening and/or closing cartridge housing 412. Actuation handle 454 may be pivotally connected to housing 450 via pivot 458 and to actuation linkage 464 via handle pivot 460. When actuation handle 454 is pulled towards grip 452, handle 454 may rotate about pivot 458 and urge actuation linkage 464 to rotate about handle pivot 460. The opposite end of actuation linkage 464 may be rotatingly connected via pivot 462 to a translating slide block 466 contained within housing 450. Alternatively, it may be desirable to configure the fixation assembly with the staple jaws preferentially biased in an open position by placing tension on actuation cable 404 with a spring placed in device handle (not shown). Upon insertion of the staple jaws into the main lumen, the jaws may be retained in a closed position by the inner diameter of the main lumen. Upon reaching the yoke portion, the jaws would be adapted to bias open into clearance slots 254 (252) to slide onto either side of presented tissue. Once the fixation has occurred, the jaws of the fixation assembly may be directed to a closed position by the yoke, and then the device main lumen as the fixation assembly is withdrawn from the patient.


Slide block 466 may anchor actuation cable 404 thereto via a mechanical anchor 470, e.g., crimps, clamps, adhesives, etc. An upper surface of slide block 466 may comprise rack 468 having a plurality of gear teeth defined thereon. When actuation handle 454 is pulled and actuation linkage 464 is urged proximally, slide block 466 may be forced proximally within travel guide 480, as indicated by arrow 488, to thereby pull actuation cable 404 proximally and thereby force cam 400 to rotate and open the cartridge housing. Simultaneously, while slide block 466 is translated proximally, rack 468 may engage and urge gear 484 to rotate clockwise in the figure, which in turn may force gear 484 to engage and urge rack 474, which is located on a lower surface of complementary slide block 472, to translate distally within travel guide 478, as indicated by arrow 486.


Complementary slide block 472 may anchor actuation cable 406 thereto via anchor 476 in the same or similar manner as anchor 470. Actuation cable 406 may be attached to anchor 476 with a retention spring 482 optionally interposed between anchor 476 and slide block 472 to take up any excess slack in the cable 406. FIG. 30B shows the handle assembly after actuation handle 454 has been actuated and slide blocks 466, 472 have been translated within their respective channels 480, 478 to fully or partially clamp cartridge housing 412 against anvil 422 over the tissue. Once cartridge housing 412 has been clamped over the folded tissue, staple deployment actuator 494 may be rotated or urged to pull staple actuation wires 420 to fire the staples into the tissue. Once staple deployment has been completed, actuation handle 454 may be urged distally to reverse the process described above to open the clamp for removal from the tissue region or for repositioning the staple assembly in another region of the tissue.


The actuation cables 404, 406 as well as staple actuation wires 420 may each be routed through flexible shaft 456, which connects handle 450 to stapler assembly 410. Flexible shaft 456 may be comprised of a tubular member having an outer sheath and an optional inner sheath, either or both of which may be made from any of the polymeric materials described above. The shaft 456 may further utilize braided materials, e.g., superelastic materials such as Nickel-Titanium alloy, integrated throughout to increase column strength and to prevent kinking. Alternatively, shaft 456 may be formed of wire (round or square flat configuration) to enhance compressive and/or tensile strength.


In a further variation, although the tissue approximation device 500 may be configured to be flexible, it may also be desirable to actively or passively curve working body 502 to assist in overall placement of the system within the target organ for optimal presentation of tissue overlap 100 prior to placement of the stapler assembly, as shown in the perspective views of FIGS. 31A and 31B. For passive actuation, a curved stylet (not shown) may be placed alongside the actuation rods in the actuation rod channels, or in another available space within the working body 502, to bias the main body 502 in the curvature provided by the stylet. Working body 502 may be optionally configured to have a bending region 504 located proximally of the acquisition assembly 512. This optional bending region 504 may be configured to facilitate bending of a portion of the working body 502 in any number of directions or only in a specified direction, depending upon the desired results.


In addition, as depicted in the detail view of FIG. 31C, a distal position control 507 may be adapted to fit onto working body 502 via a connector tube 514. Distal position control 507 may be further adapted to be integrated into handle 34 (as shown in FIG. 1). Distal position control 507 may comprise a base 506, a lever 508 configured to rotate about pivot 510 located on base 506, a linkage mechanism 516, an adjustment assembly 518, and a curvature linkage 519. An optional cap or seal 517 may be placed over a proximal end of the base 506 to seal or cover an opening to the main lumen of the working body. In operation, lever 508 may be pivotally mounted to base 506 via linkage mechanism 516. Depending on the amount of curvature desired in bending region 504, adjustment assembly 518 can be adjusted, e.g., by rotating the mechanism to adjust tension curvature linkage 519 prior to actuation of lever 508. FIG. 31A depicts the assembly 500 in the non-deployed, i.e., a straightened position of working body 502, while FIG. 31B depicts full actuation of lever 508 to impart a curvature to the distal end of working body 28. The curvature of bending region 504 may accordingly be adjusted to any intermediate position depending upon the degree of actuation of lever 508. Furthermore, although the degree of bending of the distal portion of the assembly 500 relative to a longitudinal axis of working body 502 is shown to be about 45° in this example, other variations may be adjusted to have a maximum bend of a lesser or greater degree depending upon the desired bending. Moreover, other variations may allow for bending of the assembly 500 in either a uni-directional manner or in any other direction, again depending upon the desired results. It is further contemplated that the bending region 504 may occur at a variety of locations along the shaft of working body 502, such as in the distal or proximal region of the working body or at any point therebetween.


As mentioned above, optional cap or seal 517 may be placed over a proximal end of the base 506 to seal or cover an opening to the main lumen of the working body. FIGS. 32A and 32B show perspective and end views, respectively, of a variation of end cap or seal 517 which may be used to cap the handle of FIG. 31C. End cap 517 may seal the main lumen yet allow passage of devices through the membrane through a small expandable opening 523 covering the main lumen. An optional tab or handle 521 may extend from the cap or seal 517 to facilitate handling of the cover. The cap or seal 517 may be formed from any of the polymeric materials described herein, e.g., silicone.



FIG. 33 shows a variation 520 of how the tissue approximation assembly may be utilized with other devices such as an endoscope 522. In this example, clearance slots (open region 240) may function to provide clearance for an endoscope 522, or other tool, that can be inserted into and advanced through the main lumen 40 of working body 28. Before, during, and/or after tissue approximation, endoscope 522 may be advanced distally out of main lumen 40 and advanced past acquisition assembly 16. A bending region 524 of endoscope 522 may then be retroflexed to view the results or progress of the tissue approximation and/or fixation using an imaging system 526, e.g., optical fibers, CCD or CMOS imaging system, etc., positioned within a distal end of the endoscope 522.



FIG. 34 shows a portion of flexible shaft 456 of the fixation assembly inserted through main lumen 40 of handle 110 in assembly 490. Handle 110 is partially shown for clarity. As mentioned above, one or several insertion indicators 492 may be defined along a portion of flexible shaft 456 at predetermined positions. These indicators are preferably located near a proximal end of shaft 456 to indicate information to the user. For instance, when shaft 456 is aligned against handle 110 at one particular indicator, this may notify the user when it is safe for stapler assembly 410 to be opened in a patient body, e.g., when cartridge housing 412 is positioned proximally of the tissue between the yoke members. A second indicator defined along shaft 456 may indicate to the user when the second indicator is aligned against handle 110 that it is safe to clamp stapler assembly 410 over the tissue, e.g., when stapler assembly 410 is positioned fully over the approximated and folded tissue thereby indicating that the cartridge housing 412 may be clamped against anvil 422 and the tissue for staple deployment. Additional indicators may be defined along shaft 456 to indicate various other information, e.g., positional information such as how deep stapler assembly has been inserted relative to the folder assembly. These examples are merely intended to be illustrative and are not limiting in how indicators defined along the shaft 456 may be utilized.


Once the tissue has been affixed, stapler assembly 410 may be removed from the main lumen of the folder assembly and an endoscopic device may be optionally inserted within the main lumen. The endoscopic device may be outfitted with a visual imaging system, e.g., fiberoptic, CCD, CMOS, etc., to view the tissue region. If necessary, stapler assembly 410, or some other tool, may be subsequently inserted through the main lumen to perform additional aspects of the procedure, or to complete the procedure with the placement of additional fixation elements.


In describing the system and its components, certain terms have been used for understanding, brevity, and clarity. They are primarily used for descriptive purposes and are intended to be used broadly and construed in the same manner. Having now described the invention and its method of use, it should be appreciated that reasonable mechanical and operational equivalents would be apparent to those skilled in this art. Those variations are considered to be within the equivalence of the claims appended to the specification.

Claims
  • 1. A tissue acquisition and fixation system comprising: a tissue acquisition device having an elongate main body defining a main lumen therethrough, a distal end of the acquisition device having a tissue adhering member adapted to acquire tissue from within a hollow body organ including a vacuum pod aligned on an axis of the main lumen and displaceable in a first radial direction, and first and second cavities located on opposite sides of the vacuum pod, and a tissue tensioning member adapted to tension the acquired tissue having first and second rods defining a fixed opening therebetween, where the vacuum pod is disposed in the fixed opening when the first and second rods are seated in the first and second cavities, respectively, the tissue tensioning member positioned for receiving the acquired tissue therein and wherein the tensioning member is displaceable in a second radial direction opposite the first radial direction; anda tissue fixation device adapted to be advanced through the main lumen and extending between the opening defined by the first and second rods and the vacuum pod for affixing the acquired tissue.
  • 2. The system of claim 1 wherein the tissue adhering member and the tissue tensioning member are in apposition to one another.
  • 3. The system of claim 1 wherein the tissue adhering member and the tissue tensioning member are longitudinally positioned relative to one another at a distal end of the main lumen such that the tissue fixation device is stabilized from lateral movement between the first and second rods.
  • 4. The system of claim 1 wherein the tissue tensioning member is further adapted to configure the acquired tissue into at least one fold of tissue.
  • 5. The system of claim 1 wherein the tissue fixation device comprises a flexible shaft connected to a cartridge assembly, the flexible shaft having at least one indicator defined thereon for alignment with the tissue acquisition device, wherein a position of the indicator relative to the tissue acquisition device corresponds to a predetermined position of the cartridge assembly relative to the main body.
  • 6. The system of claim 5 wherein the flexible shaft defines at least a second indicator thereon spaced apart relative to the at least one indicator.
  • 7. The system of claim 1 wherein the tissue adhering member and the tissue tensioning member are each articulatable via a corresponding actuation rod disposed along a length of the main body, wherein each actuation rod is manipulatable via its proximal end.
  • 8. The system of claim 7 wherein each actuation rod further comprises an actuation rod tubing through which each actuation rod is slidably positionable.
  • 9. The system of claim 8 wherein a distal end of each actuation rod tubing is adapted to terminate proximally of a distal end of the actuation rod, wherein each actuation rod tubing is attached near or at a distal end of the main body.
  • 10. The system of claim 1 wherein the tissue adhering member and the tissue tensioning member are each individually articulatable from a first delivery configuration to a second expanded configuration.
  • 11. The system of claim 1 wherein the tissue adhering member and the tissue tensioning member are simultaneously articulatable from a first delivery configuration to a second expanded configuration.
  • 12. The system of claim 1 further comprising at least one meshed basket positioned within the tissue adhering member.
  • 13. The system of claim 1 further comprising a first hinge member and a second hinge member each pivotally connecting a corresponding tissue adhering and tissue tensioning member to the main body.
  • 14. The system of claim 13 wherein at least one hinge member is angled relative to its corresponding member.
  • 15. The system of claim 1 further comprising a guidewire for positioning the distal end of the tissue acquisition device.
  • 16. The system of claim 1 wherein the tissue acquisition device further comprises an atraumatic distal tip.
  • 17. The system of claim 16 wherein the atraumatic distal tip is tapered.
  • 18. The system of claim 1 wherein the elongate main body of the tissue acquisition device is configured to be curved.
  • 19. The system of claim 18 wherein the elongate main body is actively or passively curved.
  • 20. The system of claim 19 wherein the elongate main body is actively curvable via a proximally located position control.
  • 21. The system of claim 1 wherein the elongate main body defines at least one bending region.
  • 22. The system of claim 21 wherein the elongate main body is adapted to be unidirectionally curved.
  • 23. The system of claim 21 wherein the elongate main body is adapted to be curved in a plurality of directions.
  • 24. The system of claim 1 further comprising a handle connected to a proximal end of the main body.
  • 25. The system of claim 24 wherein the handle further comprises at least one actuation mechanism adapted to articulate the distal end of the tissue acquisition device.
  • 26. The system of claim 1 wherein the main body is comprised of a plurality of adjacent links through which the main lumen is defined.
  • 27. The system of claim 26 wherein at least a majority of the links are adapted to pivot with respect to the adjacent link.
  • 28. The system of claim 1 wherein the tissue fixation device comprises a handle connected to a cartridge assembly via a flexible shaft.
  • 29. The system of claim 28 wherein the handle is adapted to articulate the cartridge assembly from a clamped configuration to an open configuration.
  • 30. The system of claim 28 wherein the handle is further adapted to deploy a plurality of staples from the cartridge assembly.
  • 31. The system of claim 28 wherein the cartridge assembly comprises a stapler housing and an anvil in apposition to the stapler housing.
  • 32. The system of claim 31 wherein the stapler housing is adapted to rotate about a pivot relative to the anvil from a clamped configuration to an open configuration.
  • 33. The system of claim 31 further comprising a plurality of staples positionable within the stapler housing.
  • 34. The system of claim 1 wherein the tissue fixation device is adapted to maintain a fixed orientation relative to the main lumen.
Parent Case Info

The present application is a continuation of U.S. Ser. No. 10/773,883 filed Feb. 5, 2004 now abandoned, which is herein incorporated by reference in its their entirety.

US Referenced Citations (476)
Number Name Date Kind
2108206 Meeker Feb 1938 A
2508690 Schmerl Jul 1948 A
3372443 Daddona, Jr. Mar 1968 A
3395710 Stratton et al. Aug 1968 A
3542031 Taylor Nov 1970 A
3870048 Yoon Mar 1975 A
3986493 Hendren, III Oct 1976 A
4057065 Thow Nov 1977 A
4063561 McKenna Dec 1977 A
4133315 Berman et al. Jan 1979 A
4134405 Smit Jan 1979 A
4198982 Fortner et al. Apr 1980 A
4246893 Berson Jan 1981 A
4258705 Sorensen et al. Mar 1981 A
4311146 Wonder Jan 1982 A
4315509 Smit Feb 1982 A
4343066 Lance Aug 1982 A
4402445 Green Sep 1983 A
4416267 Garren et al. Nov 1983 A
4458681 Hopkins Jul 1984 A
4473077 Noiles et al. Sep 1984 A
4485805 Foster, Jr. Dec 1984 A
4501264 Rockey Feb 1985 A
4547192 Brodsky et al. Oct 1985 A
4558699 Bashour Dec 1985 A
4592339 Kuzmak et al. Jun 1986 A
4592354 Rothfuss Jun 1986 A
4598699 Garren et al. Jul 1986 A
4607618 Angelchik Aug 1986 A
4610383 Rothfuss et al. Sep 1986 A
4636205 Steer Jan 1987 A
4641653 Rockey Feb 1987 A
4643169 Koss et al. Feb 1987 A
4646722 Silverstein et al. Mar 1987 A
4648383 Angelchik Mar 1987 A
4671287 Fiddian-Green Jun 1987 A
4694827 Weiner et al. Sep 1987 A
4696288 Kuzmak et al. Sep 1987 A
4716900 Ravo et al. Jan 1988 A
4723547 Kullas et al. Feb 1988 A
4739758 Lai et al. Apr 1988 A
4744363 Hasson May 1988 A
4773393 Haber et al. Sep 1988 A
4790294 Allred, III et al. Dec 1988 A
4795430 Quinn et al. Jan 1989 A
4803985 Hill Feb 1989 A
4841888 Mills et al. Jun 1989 A
4899747 Garren et al. Feb 1990 A
4905693 Ravo Mar 1990 A
4925446 Garay et al. May 1990 A
4927428 Richards May 1990 A
4930674 Barak Jun 1990 A
4969474 Schwarz Nov 1990 A
4990153 Richards Feb 1991 A
5037021 Mills et al. Aug 1991 A
5059193 Kuslich Oct 1991 A
5080663 Mills et al. Jan 1992 A
5084061 Gau et al. Jan 1992 A
5112310 Grobe May 1992 A
5129915 Cantenys Jul 1992 A
5146933 Boyd Sep 1992 A
5156609 Nakao et al. Oct 1992 A
5171233 Amplatz et al. Dec 1992 A
5197649 Bessler et al. Mar 1993 A
5220928 Oddsen et al. Jun 1993 A
5222961 Nakao et al. Jun 1993 A
5226429 Kuzmak Jul 1993 A
5234454 Bangs Aug 1993 A
5246456 Wilkinson Sep 1993 A
5248302 Patrick et al. Sep 1993 A
5250058 Miller et al. Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5259366 Reydel et al. Nov 1993 A
5259399 Brown Nov 1993 A
5261920 Main et al. Nov 1993 A
5263629 Trumbull et al. Nov 1993 A
5284128 Hart Feb 1994 A
5297536 Wilk Mar 1994 A
5300021 Wuchinich Apr 1994 A
5301658 Zhu et al. Apr 1994 A
5306300 Berry Apr 1994 A
5309896 Moll et al. May 1994 A
5309927 Welch May 1994 A
5327914 Shlain Jul 1994 A
5330486 Wilk Jul 1994 A
5330503 Yoon Jul 1994 A
5331975 Bonutti Jul 1994 A
5334209 Yoon Aug 1994 A
5334210 Gianturco Aug 1994 A
5345949 Shlain Sep 1994 A
5346501 Regula et al. Sep 1994 A
5355897 Pietrafitta et al. Oct 1994 A
5376095 Ortiz Dec 1994 A
5382231 Shlain Jan 1995 A
5403312 Yates et al. Apr 1995 A
5403326 Harrison et al. Apr 1995 A
5411508 Bessler et al. May 1995 A
5433721 Hooven et al. Jul 1995 A
5437291 Pasricha et al. Aug 1995 A
5449368 Kuzmak Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5458131 Wilk Oct 1995 A
5462559 Ahmed Oct 1995 A
5465894 Clark et al. Nov 1995 A
5467911 Tsuruta et al. Nov 1995 A
5486183 Middleman et al. Jan 1996 A
5489058 Plyley et al. Feb 1996 A
5503635 Sauer et al. Apr 1996 A
5527319 Green et al. Jun 1996 A
5535935 Vidal et al. Jul 1996 A
5536251 Evard et al. Jul 1996 A
5542949 Yoon Aug 1996 A
5549621 Bessler et al. Aug 1996 A
5551622 Yoon Sep 1996 A
5555898 Suzuki et al. Sep 1996 A
5558665 Kieturakis Sep 1996 A
5565004 Christoudias Oct 1996 A
5571116 Bolanos et al. Nov 1996 A
5577654 Bishop Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5584861 Swain et al. Dec 1996 A
5588579 Schnut et al. Dec 1996 A
5601604 Vincent Feb 1997 A
5603443 Clark et al. Feb 1997 A
5607094 Clark et al. Mar 1997 A
5607095 Smith et al. Mar 1997 A
5624381 Kieturakis Apr 1997 A
5626588 Sauer et al. May 1997 A
5639008 Gallagher et al. Jun 1997 A
5645564 Northrup et al. Jul 1997 A
5649937 Bito et al. Jul 1997 A
5651769 Waxman et al. Jul 1997 A
5655698 Yoon Aug 1997 A
5662260 Yoon Sep 1997 A
5662664 Gordon et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5667520 Bonutti Sep 1997 A
5676659 McGurk Oct 1997 A
5676674 Bolanos et al. Oct 1997 A
5685868 Lundquist Nov 1997 A
5690656 Cope et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5702390 Austin et al. Dec 1997 A
5704925 Otten et al. Jan 1998 A
5707382 Sierocuk et al. Jan 1998 A
5722989 Fitch et al. Mar 1998 A
5722990 Sugarbaker et al. Mar 1998 A
5728178 Buffington et al. Mar 1998 A
5735848 Yates et al. Apr 1998 A
5749893 Vidal et al. May 1998 A
5755730 Swain et al. May 1998 A
5766216 Gangal et al. Jun 1998 A
5776054 Bobra Jul 1998 A
5782844 Yoon et al. Jul 1998 A
5788715 Watson, Jr. et al. Aug 1998 A
5792153 Swain et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5810851 Yoon Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5810882 Bolduc et al. Sep 1998 A
5816471 Plyley et al. Oct 1998 A
5820584 Crabb Oct 1998 A
5824008 Bolduc et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5833690 Yates et al. Nov 1998 A
5836311 Borst et al. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5860581 Robertson et al. Jan 1999 A
5861036 Godin Jan 1999 A
5868141 Ellias Feb 1999 A
5868760 McGuckin, Jr. Feb 1999 A
5876448 Thompson et al. Mar 1999 A
5879371 Gardiner et al. Mar 1999 A
5887594 LoCicero, III Mar 1999 A
5888196 Bonutti Mar 1999 A
5897534 Heim et al. Apr 1999 A
5897562 Bolanos et al. Apr 1999 A
5904147 Conlan et al. May 1999 A
5906625 Bito et al. May 1999 A
5910105 Swain et al. Jun 1999 A
5910149 Kuzmak Jun 1999 A
5921993 Yoon Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928264 Sugarbaker et al. Jul 1999 A
5935107 Taylor et al. Aug 1999 A
5938669 Klaiber et al. Aug 1999 A
5947983 Solar et al. Sep 1999 A
5964772 Bolduc et al. Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5972001 Yoon Oct 1999 A
5972002 Bark et al. Oct 1999 A
5976161 Kirsch et al. Nov 1999 A
5980537 Ouchi Nov 1999 A
5993464 Knodel Nov 1999 A
5993473 Chan et al. Nov 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6015378 Borst et al. Jan 2000 A
6030364 Durgin et al. Feb 2000 A
6030392 Dakov Feb 2000 A
6042538 Puskas Mar 2000 A
6044847 Carter et al. Apr 2000 A
6067991 Forsell May 2000 A
6074343 Nathanson et al. Jun 2000 A
6083241 Longo et al. Jul 2000 A
6086600 Kortenbach Jul 2000 A
6113609 Adams Sep 2000 A
6119913 Adams et al. Sep 2000 A
6120513 Bailey et al. Sep 2000 A
6136006 Johnson et al. Oct 2000 A
6152923 Ryan Nov 2000 A
6159146 El Gazayerli Dec 2000 A
6159195 Ha et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6179195 Adams et al. Jan 2001 B1
6186942 Sullivan et al. Feb 2001 B1
6186985 Snow Feb 2001 B1
6197022 Baker Mar 2001 B1
6200318 Har-Shai et al. Mar 2001 B1
6206822 Foley et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6224614 Yoon May 2001 B1
6231561 Frazier et al. May 2001 B1
6248058 Silverman et al. Jun 2001 B1
6254642 Taylor Jul 2001 B1
6261307 Yoon et al. Jul 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6279809 Nicolo Aug 2001 B1
6290674 Roue et al. Sep 2001 B1
6293923 Yachia et al. Sep 2001 B1
6302917 Dua et al. Oct 2001 B1
6312437 Kortenbach Nov 2001 B1
6328689 Gonzalez et al. Dec 2001 B1
6338345 Johnson et al. Jan 2002 B1
6352543 Cole Mar 2002 B1
6358197 Silverman et al. Mar 2002 B1
6379366 Fleischmann et al. Apr 2002 B1
6387104 Pugsley, Jr. et al. May 2002 B1
6398795 McAlister et al. Jun 2002 B1
6416535 Lazarus Jul 2002 B1
6423087 Sawada Jul 2002 B1
6432040 Meah Aug 2002 B1
6447533 Adams Sep 2002 B1
6460543 Forsell Oct 2002 B1
6475136 Forsell Nov 2002 B1
6491707 Makower et al. Dec 2002 B2
6494888 Laufer et al. Dec 2002 B1
6506196 Laufer Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6535764 Imran et al. Mar 2003 B2
6540789 Silverman et al. Apr 2003 B1
6551310 Ganz et al. Apr 2003 B1
6554844 Lee et al. Apr 2003 B2
6558382 Jahns et al. May 2003 B2
6558400 Deem et al. May 2003 B2
6561969 Frazier et al. May 2003 B2
6572629 Kalloo et al. Jun 2003 B2
6579301 Bales et al. Jun 2003 B1
6582451 Marucci et al. Jun 2003 B1
6592596 Geitz Jul 2003 B1
6605037 Gresl, Jr. et al. Aug 2003 B1
6626899 Houser et al. Sep 2003 B2
6632227 Adams Oct 2003 B2
6656194 Gannoe et al. Dec 2003 B1
6663598 Carrillo, Jr. et al. Dec 2003 B1
6663639 Laufer et al. Dec 2003 B1
6663640 Kortenbach Dec 2003 B2
6663641 Kovac et al. Dec 2003 B1
6675809 Stack et al. Jan 2004 B2
6682520 Ingenito Jan 2004 B2
6682527 Strul Jan 2004 B2
6689062 Mesallum Feb 2004 B1
6692485 Brock et al. Feb 2004 B1
6716222 McAlister et al. Apr 2004 B2
6733512 McGhan May 2004 B2
6736822 McClellan et al. May 2004 B2
6740098 Abrams et al. May 2004 B2
6740121 Geitz May 2004 B2
6746460 Gannoe et al. Jun 2004 B2
6746489 Dua et al. Jun 2004 B2
6754536 Swoyer et al. Jun 2004 B2
6755849 Gowda et al. Jun 2004 B1
6755869 Geitz Jun 2004 B2
6756364 Barbier et al. Jun 2004 B2
6764518 Godin Jul 2004 B2
6773440 Gannoe et al. Aug 2004 B2
6773441 Laufer et al. Aug 2004 B1
6786898 Guenst Sep 2004 B2
6790214 Kraemer et al. Sep 2004 B2
6802868 Silverman et al. Oct 2004 B2
6821273 Mollenauer Nov 2004 B2
6821285 Laufer et al. Nov 2004 B2
6830546 Chin et al. Dec 2004 B1
6835199 McGuckin, Jr. et al. Dec 2004 B2
6835200 Laufer et al. Dec 2004 B2
6837848 Bonner et al. Jan 2005 B2
6840423 Adams et al. Jan 2005 B2
6845776 Stack et al. Jan 2005 B2
6896682 McClellan et al. May 2005 B1
6916332 Adams Jul 2005 B2
6926722 Geitz Aug 2005 B2
6932810 Ryan Aug 2005 B2
6966919 Sixto, Jr. et al. Nov 2005 B2
6981978 Gannoe Jan 2006 B2
6991643 Saadat Jan 2006 B2
6994715 Gannoe et al. Feb 2006 B2
7020531 Colliou et al. Mar 2006 B1
7025791 Levine et al. Apr 2006 B2
7033373 de la Torre et al. Apr 2006 B2
7033378 Smith et al. Apr 2006 B2
7033384 Gannoe et al. Apr 2006 B2
7037343 Imran May 2006 B2
7037344 Kagan et al. May 2006 B2
7063715 Onuki et al. Jun 2006 B2
7083629 Weller et al. Aug 2006 B2
7083630 DeVries et al. Aug 2006 B2
7087011 Cabiri et al. Aug 2006 B2
7097650 Weller et al. Aug 2006 B2
7147637 Goble Dec 2006 B2
7179254 Pendekanti et al. Feb 2007 B2
7235089 McGuckin, Jr. Jun 2007 B1
7270660 Ryan Sep 2007 B2
7288101 Deem et al. Oct 2007 B2
7306614 Weller et al. Dec 2007 B2
7361180 Saadat et al. Apr 2008 B2
7390329 Westra et al. Jun 2008 B2
7416554 Lam et al. Aug 2008 B2
7757924 Gerbi et al. Jul 2010 B2
7914543 Roth et al. Mar 2011 B2
8007505 Weller et al. Aug 2011 B2
8366709 Schechter et al. Feb 2013 B2
8430877 Kerr et al. Apr 2013 B2
20010005787 Oz et al. Jun 2001 A1
20010014800 Frazier et al. Aug 2001 A1
20010020190 Taylor Sep 2001 A1
20010037127 De Hoyos Garza Nov 2001 A1
20020022851 Kalloo et al. Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020040226 Laufer et al. Apr 2002 A1
20020047036 Sullivan et al. Apr 2002 A1
20020058967 Jervis May 2002 A1
20020072761 Abrams et al. Jun 2002 A1
20020077661 Saadat Jun 2002 A1
20020078967 Sixto, Jr. et al. Jun 2002 A1
20020082621 Schurr et al. Jun 2002 A1
20020143346 McGuckin, Jr. et al. Oct 2002 A1
20020165589 Imran et al. Nov 2002 A1
20020183768 Deem et al. Dec 2002 A1
20020193816 Laufer et al. Dec 2002 A1
20030040804 Stack et al. Feb 2003 A1
20030040808 Stack et al. Feb 2003 A1
20030065340 Geitz Apr 2003 A1
20030065359 Weller et al. Apr 2003 A1
20030093117 Saadat May 2003 A1
20030109931 Geitz Jun 2003 A1
20030109935 Geitz Jun 2003 A1
20030120285 Kortenbach Jun 2003 A1
20030120289 McGuckin, Jr. et al. Jun 2003 A1
20030132267 Adams et al. Jul 2003 A1
20030158563 McClellan et al. Aug 2003 A1
20030158601 Silverman et al. Aug 2003 A1
20030171760 Gambale Sep 2003 A1
20030208209 Gambale et al. Nov 2003 A1
20030216754 Kraemer et al. Nov 2003 A1
20030225312 Suzuki et al. Dec 2003 A1
20040006351 Gannoe et al. Jan 2004 A1
20040009224 Miller Jan 2004 A1
20040010271 Kortenbach Jan 2004 A1
20040024386 Deem et al. Feb 2004 A1
20040037865 Miller Feb 2004 A1
20040039452 Bessler Feb 2004 A1
20040044354 Gannoe et al. Mar 2004 A1
20040049209 Benchetrit Mar 2004 A1
20040059349 Sixto, Jr. et al. Mar 2004 A1
20040059354 Smith et al. Mar 2004 A1
20040059358 Kortenbach et al. Mar 2004 A1
20040082963 Gannoe et al. Apr 2004 A1
20040087977 Nolan et al. May 2004 A1
20040088008 Gannoe et al. May 2004 A1
20040089313 Utley et al. May 2004 A1
20040092892 Kagan et al. May 2004 A1
20040092974 Gannoe et al. May 2004 A1
20040097989 Molina Trigueros May 2004 A1
20040107004 Levine et al. Jun 2004 A1
20040116949 Ewers et al. Jun 2004 A1
20040122456 Saadat et al. Jun 2004 A1
20040122473 Ewers et al. Jun 2004 A1
20040122526 Imran Jun 2004 A1
20040133147 Woo Jul 2004 A1
20040133238 Cerier Jul 2004 A1
20040138525 Saadat Jul 2004 A1
20040138526 Guenst Jul 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040138531 Bonner et al. Jul 2004 A1
20040138682 Onuki et al. Jul 2004 A1
20040147958 Lam et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040148034 Kagan et al. Jul 2004 A1
20040158331 Stack et al. Aug 2004 A1
20040162568 Saadat Aug 2004 A1
20040167546 Saadat et al. Aug 2004 A1
20040172141 Stack et al. Sep 2004 A1
20040181242 Stack et al. Sep 2004 A1
20040193190 Liddicoat et al. Sep 2004 A1
20040210243 Gannoe et al. Oct 2004 A1
20040215180 Starkebaum et al. Oct 2004 A1
20040225183 Michlitsch et al. Nov 2004 A1
20040225194 Smith et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20040236357 Kraemer et al. Nov 2004 A1
20040249362 Levine et al. Dec 2004 A1
20050010162 Utley et al. Jan 2005 A1
20050015113 Baptiste et al. Jan 2005 A1
20050033328 Laufer et al. Feb 2005 A1
20050038415 Rohr et al. Feb 2005 A1
20050049718 Dann et al. Mar 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055039 Burnett et al. Mar 2005 A1
20050075622 Levine et al. Apr 2005 A1
20050075653 Saadat et al. Apr 2005 A1
20050080438 Weller et al. Apr 2005 A1
20050080444 Kraemer et al. Apr 2005 A1
20050085787 Laufer Apr 2005 A1
20050096750 Kagan et al. May 2005 A1
20050119671 Reydel et al. Jun 2005 A1
20050119674 Gingras Jun 2005 A1
20050124987 Goble Jun 2005 A1
20050143760 Imran Jun 2005 A1
20050148818 Mesallum Jul 2005 A1
20050149067 Takemoto et al. Jul 2005 A1
20050149114 Cartledge et al. Jul 2005 A1
20050177176 Gerbi et al. Aug 2005 A1
20050192599 Demarais Sep 2005 A1
20050192601 Demarais Sep 2005 A1
20050194038 Brabec et al. Sep 2005 A1
20050194294 Oexle et al. Sep 2005 A1
20050194312 Niemeyer et al. Sep 2005 A1
20050195925 Traber Sep 2005 A1
20050195944 Bartels et al. Sep 2005 A1
20050196356 Leinen et al. Sep 2005 A1
20050197540 Liedtke Sep 2005 A1
20050197622 Blumenthal et al. Sep 2005 A1
20050197684 Koch Sep 2005 A1
20050198476 Gazsi et al. Sep 2005 A1
20050203547 Weller et al. Sep 2005 A1
20050203548 Weller et al. Sep 2005 A1
20050228415 Gertner Oct 2005 A1
20050228504 Demarais Oct 2005 A1
20050256533 Roth et al. Nov 2005 A1
20050256587 Egan Nov 2005 A1
20060020247 Kagan et al. Jan 2006 A1
20060020254 Hoffmann Jan 2006 A1
20060020276 Saadat et al. Jan 2006 A1
20060036267 Saadat et al. Feb 2006 A1
20060106288 Roth et al. May 2006 A1
20060111735 Crainich May 2006 A1
20060122462 Roth et al. Jun 2006 A1
20060142787 Weller et al. Jun 2006 A1
20060149316 DeVries et al. Jul 2006 A1
20060151568 Weller et al. Jul 2006 A1
20060241692 McGuckin et al. Oct 2006 A1
20070112358 Abbott et al. May 2007 A1
20070162056 Gerbi et al. Jul 2007 A1
20070219571 Balbierz et al. Sep 2007 A1
20070265640 Kortenbach et al. Nov 2007 A1
20080029576 Shelton et al. Feb 2008 A1
20080128470 McAlister et al. Jun 2008 A1
20080217375 Scirica et al. Sep 2008 A1
20090048596 Shields et al. Feb 2009 A1
20090125040 Hambly et al. May 2009 A1
20110046623 Reschke Feb 2011 A1
20110166585 Roth et al. Jul 2011 A1
20120037686 Hessler Feb 2012 A1
20120165844 Roth et al. Jun 2012 A1
20120197269 Zammataro Aug 2012 A1
Foreign Referenced Citations (51)
Number Date Country
0 137 878 Apr 1985 EP
0 174 843 Mar 1986 EP
0 246 999 Nov 1987 EP
0 540 010 May 1993 EP
63277063 Nov 1988 JP
63279854 Nov 1988 JP
63302863 Dec 1988 JP
01049572 Feb 1989 JP
04297219 Oct 1992 JP
WO 9418893 Sep 1994 WO
WO 9917662 Apr 1999 WO
WO 9953827 Oct 1999 WO
WO 0032137 Jun 2000 WO
WO 0039708 Jul 2000 WO
WO 0048656 Aug 2000 WO
WO 0078227 Dec 2000 WO
WO 0078229 Dec 2000 WO
WO 0166018 Sep 2001 WO
WO 0167964 Sep 2001 WO
WO 0185034 Nov 2001 WO
WO 0224080 Mar 2002 WO
WO 0235980 May 2002 WO
WO 0239880 May 2002 WO
WO 02071951 Sep 2002 WO
WO 02091961 Nov 2002 WO
WO 02096327 Dec 2002 WO
WO 03007796 Jan 2003 WO
WO 03017882 Mar 2003 WO
WO 03078721 Sep 2003 WO
WO 03086247 Oct 2003 WO
WO 03088844 Oct 2003 WO
WO 03094785 Nov 2003 WO
WO 03099140 Dec 2003 WO
WO 03105563 Dec 2003 WO
WO 03105671 Dec 2003 WO
WO 2004009269 Jan 2004 WO
WO 2004014237 Feb 2004 WO
WO 2004017863 Mar 2004 WO
WO 2004019787 Mar 2004 WO
WO 2004019826 Mar 2004 WO
WO 2004037064 May 2004 WO
WO 2004049911 Jun 2004 WO
WO 2004058102 Jul 2004 WO
WO 2004060150 Jul 2004 WO
WO 2004087014 Oct 2004 WO
WO 2004103189 Dec 2004 WO
WO 2005023118 Mar 2005 WO
WO 2005037152 Apr 2005 WO
WO 2005058239 Jun 2005 WO
WO 2005060882 Jul 2005 WO
WO 2006078781 Jul 2006 WO
Non-Patent Literature Citations (34)
Entry
Benjamin, S.B., et al., A Double-Blind Cross Over Study of the Garren-Edwards anti-Obesity Bubblem Abstract Submitted to A/S/G/E/ 1987, Georgetown University Hospital and Fairfax Hospital, Washington, D.C. and Fairfax, VA.
Benjamin, S.B., Small Bowel Obstruction and the Garren-Edwards Bubble, Lessons to be Learned? Abstracts Submitted to A/S/G/E 1987, Division of Gastroenterology, Department of Medicine, Georgetown University Hospital, Washington, D.C.
Boyle, Thomas M., M.D., et al., Small Intestinal Obstruction Secondary to Obturation by a Garren Gastric Bubble, The American Journal of Gastroenterology, vol. 82, No. 1, pp. 51-53, 1987.
Bütchler, M.W., M.D. et al., A Technique For Gastroplasty As A Substitute For The Esophagus: Fundus Rotation Gastroplasty, Journal Of The American College of Surgeons, vol. 182, pp. 241-245, Mar. 1996.
Cass, O.W., et al., Long-Term Follow-Up of Patients With Percutaneous Endoscopic Gastrostomy (PEG), Abstracts Submitted to A/S/G/E 1987, Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415.
Chang, Craig G. M.D. 1 , et al.. Gastro-Clip® Gastroplasty: A Very Long-Term Complication Obesity Surgery, ® FD-Communications Inc.. 2004.
Clark, Charlene, R.N., The Gastric Bubble: Medicine, Magic or Mania? SGA Journal, vol. 9, No. 2, pp. 45-47, Fall 1986.
Cummings, David E., M.D., et al., Plasma Ghrelin Levels After Diet-Induced Weight Loss or Gastric Bypass Surgery, New England Journal of Medicine, vol. 346, No. 21, pp. 1623-1630, May 23, 2002.
Davenport, Horace W., Ph.D., D.Sc., Physiology of the Digestive Tract: An Introductory Text, 3d Ed., Cover and Table of Contents.
DeMeester, Torn T., M.D., Evolving Concepts of Reflux: The Ups and Downs of the LES, Canadian Journal of Gastroenterology, vol. 16, No. 5, pp. 327-331, 2002.
De Waele, B., M.D., et al., Intragastric Balloons for Preoperative Weight Reduction, Obesity Surgery, vol. 10, pp. 58-60, 2000.
Edell, Steven L., et al., Radiographic Evaluation of the Garren Gastric Bubble, American Journal of Radiology, vol. 145, pp. 49-50, Jul. 1985.
Endo Gia* Universal, Single UseStapler and Endo GIA Roticulator*, Brochure, 8 pages, Undated.
Filipi, Charles J. M.D., et al., Transoral, Flexible Endoscopic Suturing For Treatment Of GERD: A Multicenter Trial, Gastrointestinal Endoscopy,. vol. 53, No. 4, pp. 416-422, 2001.
Gray, Henry, R.R.S., Anatomy of the Human Body, The Digestive System, Thirtieth American Edition, pp. 1466-1467 (Undated).
Guidant, Internet, AXIUS™ VACUUM 2 Stabilizer Systems, Internet Website—www.guidant.com/products/axius—vacuum.shtml, 8 pages, visited May 27, 2003.
Gukovsky-Reicher, S., M.D. et al., Expandable Metal Esophageal Stents: Efficacy and Safety. Review of Current Literature Data and of 53 Stents Placed at Harbor-UCLA Medical Center, www.medscape.com/viewarticle/423508—print—pp. 1-20, Medscape General Medicine 4(1), 2003 © 2002 Medscape, download Oct. 9, 2006.
Hepworth, Clive C. FRCS et al., Mechanical Endoscopic Methods Of Haemostasis For Bleeding Peptic Ulcers: A Review, Bailliere's Clinical Gastroenterology, vol. 14, No. 3 pp. 467-476, 2000.
Ikeda, Y. et al., New Suturing Device For Transanal Endoscopic Microsurgery, Blackwell Science Ltd. p. 1290, 1997.
Johnson & Johnson GatewaySM Endopath 3mm, 5mm and 10 mm Diameter Endoscopic Instruments, Internet Website—www.inigateway.com/home.ihtml?loc=USENG&pape=viewContent&parentId-0900 . . . , 3 pages, visited May 29, 2003.
Kirby, Donald F., Incomplete Small Bowel Obstruction by the Garren-Edwards Gastric Bubble Necessitating Surgical Intervention, The American Journal of Gastroenterology, vol. 82, No. 3, pp. 251-253, 1987.
Nieben, Ole Gyring, et al., Intragastric Balloon as an Artificial Bezoar for Treatment of Obesity, The Lancet, pp. 198-199, Jan. 23, 1982.
Percival, Walter L., M.D., “The Balloon Diet”: A Noninvasive Treatment for Morbid Obesity. Preliminary Report of 1908 Patients, The Canadian Journal of Surgery, vol. 27, No. 2, pp. 135-136.
Power Medical Interventions Digital and Wireless Medical Technology, Product Innovation: SurgASSIST™, Internet Website—www/pmi2.com/access—flexibility.asp, 6 pages, visited May 29, 2003.
Snowden Pencer, Diamon-Flex Angled Snake Retractor (class 1, 878.4800), Appendix F.f, Undated.
Stoltenberg, P.H., et al., Intragastric Balloon Therapy of Obesity: A Randomized Double-Blind Trial, Abstracts of Papers 1985, Scott & White Clinic, Texas A&M College of Medicine, Temple, Texas.
Swain, C. Paul, M.D. et al., An Endoscopic Sewing Machine, Gastrointestinal Edoscopy, vol. 32, No. 1 pp. 36-38. 1986.
Swain, C. Paul, M.D., Endoscopic Sewing And Stapling Machines, Endoscopy pp. 205-210, © Georg Thieme Verlag Stuttgart, New York, 1997.
Swain, C. Paul, M.D. et al., An Endoscopic Stapling Device: The Development Of A New Flexible Endoscopically Controlled Device For Placing Multiple Transmural Staples In Gastrointestinal Tissue, Gastrointestinal Endoscopy, vol. 35. No. 4, pp. 338-339, 1989.
Swain, C. Paul, M.D., Endoscopic Suturing, Bailliere's Clinical Gastroenterology, Bailliere's Tindall vol. 13 No. 1, pp. 97-108, 1999.
Taylor, T. Vincent, et al., Gastric Balloons for Obesity, The Lancet, Abstract, Mar. 27, 1982.
Vandenplas, Y., et al., Intragastric Balloons in Adolescents With Morbid Obesity, European Journal of Gastroenterology & Hepatology, vol. 11, No. 3, pp. 243-245, 1999.
Villar, Hugo V., M.D., et al., Mechanisms of Satiety and Gastric Emptying After Gastric Partitioning and Bypass, Surgery, pp. 229-236, Aug. 1981.
Wullstein, C., et al., Compression Anastomosis (AKA-2) in Colorectal Surgery: Results in 442 Consecutive Patients, British Journal of Surgery, 2000, pp. 1071-1075.
Related Publications (1)
Number Date Country
20070162056 A1 Jul 2007 US
Continuations (1)
Number Date Country
Parent 10773883 Feb 2004 US
Child 11716157 US